<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003528.pub2" GROUP_ID="MUSKEL" ID="621501080621440707" MERGED_FROM="" MODIFIED="2014-10-28 17:12:21 +0000" MODIFIED_BY="Elizabeth Tanjong Ghogomu" REVIEW_NO="C026-R" REVMAN_SUB_VERSION="5.3.4 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.61">
<COVER_SHEET MODIFIED="2014-10-28 13:01:39 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2013-11-22 11:21:33 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Should title be changed to reflect the patients who were eligible; ie, only lateral elbow pain or lateral knee pain (and not say, shoulder pain?).&lt;/p&gt;&lt;p&gt;Query if the review should be split to two titles- one addressing lateral elbow pain; and one addressing lateral knee pain&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-11-22 11:21:33 -0500" NOTES_MODIFIED_BY="[Empty name]">Deep transverse friction massage for treating lateral elbow or lateral knee tendinitis</TITLE>
<CONTACT>
<PERSON ID="9058" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Lucie</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Brosseau</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>Lucie.Brosseau@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences, Faculty of Health Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613-562-5800 ext: 8015</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613-562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2014-10-28 13:01:39 -0400" MODIFIED_BY="[Empty name]">
<PERSON ID="90836002111458452737111031171459" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Laurianne</FIRST_NAME>
<MIDDLE_INITIALS>M</MIDDLE_INITIALS>
<LAST_NAME>Loew</LAST_NAME>
<SUFFIX/>
<POSITION>Research Assistant</POSITION>
<EMAIL_1>lloew079@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences, Faculty of Health Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 ext 8393</PHONE_1>
<PHONE_2/>
<FAX_1>613-562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="9058" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Lucie</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Brosseau</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>Lucie.Brosseau@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences, Faculty of Health Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613-562-5800 ext: 8015</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613-562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5474" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Tugwell</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Medicine, &amp; Epidemiology and Community Medicine, Canada</POSITION>
<EMAIL_1>tugwell.bb@uottawa.ca</EMAIL_1>
<EMAIL_2>kerry.obrien@uottawa.ca</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Medicine</DEPARTMENT>
<ORGANISATION>Faculty of Medicine, University of Ottawa</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 ext: 1945</PHONE_1>
<PHONE_2/>
<FAX_1>613-562-5659</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12662" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>George</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Wells</LAST_NAME>
<SUFFIX>MSc, PhD</SUFFIX>
<POSITION>Professor</POSITION>
<EMAIL_1>gawells@ottawaheart.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Epidemiology and Community Medicine</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>Room H1281</ADDRESS_1>
<ADDRESS_2>40 Ruskin Street</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1Y 4W7</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 798 5555 x18640</PHONE_1>
<PHONE_2>+1 613 798 5555 x18642</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="13312" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Vivian</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Welch</LAST_NAME>
<SUFFIX/>
<POSITION>Associate Scientist</POSITION>
<EMAIL_1>vivian.welch@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>1 613 219 9290</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Bruyère Research Institute</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>43 Bruyere Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1N 5C8</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 562-6262 x1352</PHONE_1>
<PHONE_2>+1 613 562-5800 ext 2921</PHONE_2>
<FAX_1>+1 613 562-5659</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5440" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Beverley</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Shea</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION>Adjunct Professor</POSITION>
<EMAIL_1>bevshea@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Epidemiology and Community Medicine</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>501 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8L6</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 562 5800 ext: 8571</PHONE_1>
<PHONE_2>+1 613 276 7396</PHONE_2>
<FAX_1>+1 613 562 5392</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="40103371218558793229110315185546" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Stephane</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Poitras</LAST_NAME>
<SUFFIX/>
<POSITION>Professor</POSITION>
<EMAIL_1>Stephane.poitras@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences, Faculty of Health Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613 562-5800 x8121</PHONE_1>
<PHONE_2/>
<FAX_1>613 562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="39221610671753160579110622000044" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Gino</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>De Angelis</LAST_NAME>
<SUFFIX/>
<POSITION>Research Coordinator</POSITION>
<EMAIL_1>gdean053@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Epidemiology and Community Medicine</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP/>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z1407151846207246449913226776849" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Prinon</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Rahman</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>prinonrahman@yahoo.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences, Faculty of Health Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H8M5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2014-10-07 14:59:02 -0400" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="1" MONTH="7" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="7" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="7" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="" YEAR=""/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2002"/>
<LAST_CITATION_ISSUE ISSUE="10" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-10-26 18:15:45 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-10-26 18:15:45 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="7" YEAR="2014"/>
<DESCRIPTION>
<P>New review authors</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-10-26 18:15:36 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="7" YEAR="2014"/>
<DESCRIPTION>
<P>New search; no new studies<BR/>Added risk of bias tables, summary of findings table and new excluded articles</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2012-04-23 11:59:18 -0400" MODIFIED_BY="[Empty name]"/>
<SOURCES_OF_SUPPORT MODIFIED="2011-03-15 14:06:42 -0400" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Institute for Population Health, University of Ottawa</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Ottawa Health Research Institute</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2011-03-15 14:06:42 -0400" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2011-03-15 14:06:42 -0400" MODIFIED_BY="[Empty name]">
<NAME>Holistic Health Research Foundation of Canada</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-10-28 13:03:02 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2014-10-27 04:17:08 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2014-06-19 08:56:35 -0400" MODIFIED_BY="[Empty name]">Deep transverse friction massage for the treatment of lateral elbow or lateral knee tendinitis</TITLE>
<SUMMARY_BODY MODIFIED="2014-10-27 04:17:08 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Review question</B>
</P>
<P>We conducted an update of the review of the effects of deep transverse friction massage (DTFM) for people with lateral elbow or knee tendinitis. We found two studies (no new additional studies in this update) with 57 people.</P>
<P>
<B>Background: what is tendinitis and what is deep tendon friction massage?</B>
</P>
<P>Tendons are fibrous structures that attach muscle to bone. Tendinitis essentially is seen when a tendon suffers from inflammation (painful swelling). The inflammation is due to too much stress on the tendon caused by performing repetitive movements. This causes pain and stiffness in the joint such as the elbow or the knee.</P>
<P>Deep transverse friction massage (DTFM) is a physical therapy technique often used to reduce damage and scarring caused by inflammation. It increases blood flow to the joint, which facilitates healing of the tendon by increasing the supply of oxygen transported to the injury.</P>
<P>
<B>Study characteristics</B>
</P>
<P>One study with a duration of five weeks reviewed (1) the effects of deep transverse friction massage combined with therapeutic ultrasound and placebo ointment compared with therapeutic ultrasound and placebo ointment in 20 people with lateral elbow tendinitis (tennis elbow), as well as (2) the effects of deep transverse friction massage combined with phonophoresis compared with phonophoresis alone in 20 people with lateral elbow tendinitis (tennis elbow). The other study, with a duration of two weeks, reviewed the effects of deep transverse friction massage with physical therapy intervention compared with physical therapy intervention alone in 17 people with lateral knee tendinitis.</P>
<P>
<B>Key results</B>
</P>
<P>
<B>What happens to people with lateral elbow tendinitis (tennis elbow) who are treated with deep transverse friction massage?</B>
</P>
<P>&#8226; We are uncertain whether deep transverse friction massage improves pain and function (very low-quality evidence).</P>
<P>&#8226; No studies reported pain relief of 30% or greater, quality of life, patient global assessment, adverse events, and withdrawals due to adverse events.</P>
<P>We often do not have precise information about side effects and complications. This is particularly true for rare but serious side effects.</P>
<P>
<B>What happens to people with lateral knee tendinitis who are treated with deep transverse friction massage?</B>
</P>
<P>&#8226; We are uncertain whether deep transverse friction massage improves pain (very low-quality evidence).</P>
<P>&#8226; No studies reported pain relief of 30% or greater, function, quality of life, patient global assessment, adverse events, and withdrawals due to adverse events.</P>
<P>We often do not have precise information about side effects and complications. This is particularly true for rare but serious side effects.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-10-28 13:02:29 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2014-10-26 18:18:38 -0400" MODIFIED_BY="[Empty name]">
<P>Deep transverse friction massage, one of several physical therapy interventions suggested for the management of tendinitis pain, was first demonstrated in the 1930s by Dr James Cyriax, a renowned orthopedic surgeon in England. Its goal is to prevent abnormal fibrous adhesions and abnormal scarring. This is an update of a Cochrane review first published in 2001.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-12-09 11:59:38 -0500" MODIFIED_BY="[Empty name]">
<P>To assess the benefits and harms of deep transverse friction massage for treating lateral elbow or lateral knee tendinitis.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-10-26 18:50:30 -0400" MODIFIED_BY="[Empty name]">
<P>We searched the following electronic databases: the specialized central registry of the Cochrane Field of Physical and Related Therapies, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Clinicaltrials.gov, and the Physiotherapy Evidence Database (PEDro), up until July 2014. The reference lists of these trials were consulted for additional studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-10-27 04:11:46 -0400" MODIFIED_BY="[Empty name]">
<P>All randomized controlled trials (RCTs) and controlled clinical trials (CCTs) comparing deep transverse friction massage with control or other active interventions for study participants with two eligible types of tendinitis (ie, extensor carpi radialis tendinitis (lateral elbow tendinitis, tennis elbow or lateral epicondylitis or lateralis epicondylitis humeri) and iliotibial band friction syndrome (lateral knee tendinitis)) were selected. Only studies published in English and French languages were included.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-10-27 04:12:13 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed the studies on the basis of inclusion and exclusion criteria. Results of individual trials were extracted from the included study using extraction forms prepared by two independent review authors before the review was begun. Data were cross-checked by a third review author. Risk of bias of the included studies was assessed using the "Risk of bias" tool of The Cochrane Collaboration. A pooled analysis was performed using mean difference (MD) for continuous outcomes and risk ratio (RR) for dichotomous outcomes with 95% confidence intervals (CIs).</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-10-28 13:02:29 -0400" MODIFIED_BY="[Empty name]">
<P>Two RCTs (no new additional studies in this update) with 57 participants met the inclusion criteria. These studies demonstrated high risk of performance and detection bias, and the risk of selection, attrition, and reporting bias was unclear.</P>
<P>The first study included 40 participants with lateral elbow tendinitis and compared (1) deep transverse friction massage combined with therapeutic ultrasound and placebo ointment (n = 11) versus therapeutic ultrasound and placebo ointment only (n = 9) and (2) deep transverse friction massage combined with phonophoresis (n = 10) versus phonophoresis only (n = 10). No statistically significant differences were reported within five weeks for mean change in pain on a 0 to 100 visual analog scale (VAS) (MD -6.60, 95% CI -28.60 to 15.40; 7% absolute improvement), grip strength measured in kilograms of force (MD 0.10, 95% CI -0.16 to 0.36) and function on a 0 to 100 VAS (MD -1.80, 95% CI -0.18.64 to 15.04; 2% improvement), pain-free function index measured as the number of pain-free items (MD 1.10, 95% CI -1.00 to 3.20) and functional status (RR 3.3, 95% CI 0.4 to 24.3) for deep transverse friction massage, and therapeutic ultrasound and placebo ointment compared with therapeutic ultrasound and placebo ointment only. Likewise for deep transverse friction massage and phonophoresis compared with phonophoresis alone, no statistically significant differences were found for pain (MD -1.2, 95% CI -20.24 to 17.84; 1% improvement), grip strength (MD -0.20, 95% CI -0.46 to 0.06) and function (MD 3.70, 95% CI -14.13 to 21.53; 4% improvement). In addition, the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach was used to evaluate the quality of evidence for the pain outcome, which received a score of "very low". Pain relief of 30% or greater, quality of life, patient global assessment, adverse events, and withdrawals due to adverse events were not assessed or reported.</P>
<P>The second study included 17 participants with iliotibial band friction syndrome (knee tendinitis) and compared deep transverse friction massage with physical therapy intervention versus physical therapy intervention alone, at two weeks. Deep transverse friction massage with physical therapy intervention showed no statistically significant differences in the three measures of pain relief on a 0 to 10 VAS when compared with physical therapy alone: daily pain (MD -0.40, 95% CI -0.80 to -0.00; absolute improvement 4%), pain while running (scale from 0 to 150) (MD -3.00, 95% CI -11.08 to 5.08), and percentage of maximum pain while running (MD -0.10, 95% CI -3.97 to 3.77). For the pain outcome, absolute improvement showed a 4% reduction in pain. However, the quality of the body of evidence received a grade of &#8220;very low.&#8221; Pain relief of 30% or greater, function, quality of life, patient global assessment of success, adverse events, and withdrawals due to adverse events were not assessed or reported.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-10-26 19:00:55 -0400" MODIFIED_BY="[Empty name]">
<P>We do not have sufficient evidence to determine the effects of deep transverse friction on pain, improvement in grip strength, and functional status for patients with lateral elbow tendinitis or knee tendinitis, as no evidence of clinically important benefits was found. The confidence intervals of the estimate of effects overlapped the null value for deep transverse friction massage in combination with physical therapy compared with physical therapy alone in the treatment of lateral elbow tendinitis and knee tendinitis. These conclusions are limited by the small sample size of the included randomized controlled trials. Future trials, utilizing specific methods and adequate sample sizes, are needed before conclusions can be drawn regarding the specific effects of deep transverse friction massage on lateral elbow tendinitis.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-10-28 13:03:02 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2014-10-27 11:01:54 -0400" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<CONDITION MODIFIED="2014-10-27 11:01:54 -0400" MODIFIED_BY="[Empty name]">
<P>Extensor carpi radialis tendinitis (ECRT) (ie, lateral elbow tendinitis, tennis elbow or lateral epicondylitis, or lateralis epicondylitis humeri) is a local inflammation near the proximal (upper) attachments of wrist extensor muscles, characterized by pain on palpation of the lateral epicondyle of the humerus and in resisted movements against wrist extension (<LINK REF="REF-Struijs-2002" TYPE="REFERENCE">Struijs 2002</LINK>). The prevalence of lateral elbow tendinitis (tennis elbow) varies between 1% and 10% of the population; it commonly occurs between the ages of 34 and 74 years (<LINK REF="REF-Allander-1974" TYPE="REFERENCE">Allander 1974</LINK>; <LINK REF="REF-Roquelaure-2006" TYPE="REFERENCE">Roquelaure 2006</LINK>; <LINK REF="REF-Shiri-2006" TYPE="REFERENCE">Shiri 2006</LINK>; <LINK REF="REF-Walker_x002d_Bone-2004" TYPE="REFERENCE">Walker-Bone 2004</LINK>). <LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK> reported that lateral elbow tendinitis (tennis elbow) does not seem to be a degenerative condition, as its prevalence declines after the age of 42 (<LINK REF="REF-Allander-1974" TYPE="REFERENCE">Allander 1974</LINK>). It is a syndrome of overuse (eg, use of computer mouse, racquet sports) that can result in considerable socioeconomic costs resulting from prolonged leave of absence from work (<LINK REF="REF-Struijs-2002" TYPE="REFERENCE">Struijs 2002</LINK>).</P>
<P>Iliotibial band friction syndrome (ITBFS) (lateral knee tendinitis) is an overuse musculoskeletal injury that causes lateral knee pain and is frequently observed in long distance runners, cyclists, football players, and military personnel. The incidence of lateral knee tendinitis varies between 1.6% and 52%, depending upon the population studied (<LINK REF="REF-Jordaan-1994" TYPE="REFERENCE">Jordaan 1994</LINK>; <LINK REF="REF-Kirk-2000" TYPE="REFERENCE">Kirk 2000</LINK>; <LINK REF="REF-Lavine-2010" TYPE="REFERENCE">Lavine 2010</LINK>; <LINK REF="REF-Pinshaw-1984" TYPE="REFERENCE">Pinshaw 1984</LINK>; <LINK REF="REF-Strauss-2011" TYPE="REFERENCE">Strauss 2011</LINK>). The mechanism of lateral knee tendinitis appears to be repetitive friction of the iliotibial band moving over the lateral femoral condyle during knee flexion/extension (<LINK REF="REF-Schwellnus-1991" TYPE="REFERENCE">Schwellnus 1991</LINK>). The cause of ITBFS (lateral knee tendinitis) is multifactorial (<LINK REF="REF-Messier-1988" TYPE="REFERENCE">Messier 1988</LINK>). Three main risk factors play a large role in the development of lateral knee tendinitis, according to the current literature: (1) biomechanical factors such as muscle imbalance causing maximal braking forces required to control body movements depending on velocity and angle of inclination (<LINK REF="REF-Messier-1995" TYPE="REFERENCE">Messier 1995</LINK>), (2) anthropometric factors such as abnormalities in leg and/or feet anatomy (<LINK REF="REF-Messier-1988" TYPE="REFERENCE">Messier 1988</LINK>), and (3) training factors such as inadequate warm-up and cool-down training (<LINK REF="REF-Messier-1988" TYPE="REFERENCE">Messier 1988</LINK>; <LINK REF="REF-Messier-1995" TYPE="REFERENCE">Messier 1995</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-10-27 04:01:48 -0400" MODIFIED_BY="[Empty name]">
<P>Treatment of tendinitis consists of medical, physiotherapeutic, and surgical approaches. The medical approach encompasses rest and the prescription of anti-inflammatory agents combined with anti-inflammatory or analgesic medication to control pain and inflammation (<LINK REF="REF-Kirk-2000" TYPE="REFERENCE">Kirk 2000</LINK>). Goals of the physiotherapeutic approach in the treatment of tendinitis include (1) control of pain and inflammation (<LINK REF="REF-Cyriax-1975a" TYPE="REFERENCE">Cyriax 1975a</LINK>; <LINK REF="REF-Cyriax-1975b" TYPE="REFERENCE">Cyriax 1975b</LINK>; <LINK REF="REF-Thaunton-1987" TYPE="REFERENCE">Thaunton 1987</LINK>; <LINK REF="REF-Wilk-2004" TYPE="REFERENCE">Wilk 2004</LINK>); (2) correction of biomechanical deficiencies (<LINK REF="REF-Johnson-2007" TYPE="REFERENCE">Johnson 2007</LINK>; <LINK REF="REF-Thaunton-1987" TYPE="REFERENCE">Thaunton 1987</LINK>); (3) restoration of motion (<LINK REF="REF-Hart-1994" TYPE="REFERENCE">Hart 1994</LINK>); (4) increase in strength, endurance, and function (<LINK REF="REF-Hart-1994" TYPE="REFERENCE">Hart 1994</LINK>; <LINK REF="REF-Reinold-2002" TYPE="REFERENCE">Reinold 2002</LINK>; <LINK REF="REF-Thaunton-1987" TYPE="REFERENCE">Thaunton 1987</LINK>; <LINK REF="REF-Wilk-2004" TYPE="REFERENCE">Wilk 2004</LINK>); (5) prevention of reinjury (<LINK REF="REF-Hart-1994" TYPE="REFERENCE">Hart 1994</LINK>; <LINK REF="REF-Reinold-2002" TYPE="REFERENCE">Reinold 2002</LINK>); and (6) gradual return to training (<LINK REF="REF-Reinold-2002" TYPE="REFERENCE">Reinold 2002</LINK>; <LINK REF="REF-Thaunton-1987" TYPE="REFERENCE">Thaunton 1987</LINK>). The surgical approach includes resection of the impinging portion of the extensor carpi radialis brevis tendon release (<LINK REF="REF-Grewal-2009" TYPE="REFERENCE">Grewal 2009</LINK>) or the iliotibial band (<LINK REF="REF-Kirk-2000" TYPE="REFERENCE">Kirk 2000</LINK>; <LINK REF="REF-Martens-1989" TYPE="REFERENCE">Martens 1989</LINK>).</P>
<P>Deep transverse friction massage (DTFM) is a technique popularized by Dr James Cyriax (<LINK REF="REF-Cyriax-1975a" TYPE="REFERENCE">Cyriax 1975a</LINK>; <LINK REF="REF-Cyriax-1975b" TYPE="REFERENCE">Cyriax 1975b</LINK>) for relief of pain and inflammation in musculoskeletal conditions. Deep friction is given transverse to the fiber direction of involved tissue, and friction massage must be sufficiently deep to impact the affected structure.</P>
</INTERVENTION>
<THEORY MODIFIED="2014-10-26 19:15:15 -0400" MODIFIED_BY="[Empty name]">
<P>Deep transverse friction massage is offered in the treatment of various musculoskeletal conditions. This technique attempts to prevent or destroy abnormal fibrous adhesions (cross-links or cross-bridges) by imposing stress transversely to the remodeling collagen of the tissue to soften the adhesion. Thus, DTFM also optimizes the quality of the scar tissue by realigning the collagen of normal soft tissue fibers in a longitudinal way (<LINK REF="REF-Walker-1984" TYPE="REFERENCE">Walker 1984</LINK>). It has been indicated that DTFM enhances normal healing conditions and prevents abnormal scarring. Its mechanical action causes hyperemia (ie, an increase in blood flow to the affected area).</P>
</THEORY>
<IMPORTANCE MODIFIED="2014-10-26 19:15:52 -0400" MODIFIED_BY="[Empty name]">
<P>No meta-analyses or literature reviews have reported the efficacy of this type of massage for lateral elbow or knee tendinitis. Clinicians and patients must be provided with evidence that will enable them to make informed decisions regarding treatment options.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-12-09 12:00:02 -0500" MODIFIED_BY="[Empty name]">
<P>To assess the benefits and harms of deep transverse friction massage for treating lateral elbow or lateral knee tendinitis.</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-10-28 13:03:02 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2014-10-27 04:21:28 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2014-10-27 04:20:01 -0400" MODIFIED_BY="[Empty name]">
<P>According to an a priori protocol, randomized controlled trials (RCTs) and controlled clinical trials (CCTs) (and CCTs with pseudorandom methods of allocating participants to treatment) were selected because they are defined as comparative controlled trials with the presence of comparison groups, which allow evaluation of DTFM and patients with tendinitis pain compared with other types of interventions and populations. Only articles published in the English language or the French language were included.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-10-27 04:20:41 -0400" MODIFIED_BY="[Empty name]">
<P>Studies were included if study participants were 18 years of age or older and had been diagnosed with tendinitis (lateral elbow tendinitis and knee tendinitis). Participants had to show no signs of psychiatric conditions and had to demonstrate stable physical and medical status. Mixed populations (individuals with multiple conditions other than tendinitis) were not permitted. Inclusion criteria for lateral elbow tendinitis comprised (1) tenderness on palpation over the lateral aspect of the elbow and (2) pain in the lateral aspect of the elbow during resisted wrist extension. For knee tendinitis, inclusion criteria consisted of (1) history of pain on the lateral aspect of the knee during running, (2) tenderness over the lateral femoral condyle at rest, and (3) aggravation of symptoms at 30 degrees of knee flexion. For the complete list of exclusion criteria and the PICOTS (populations, interventions, comparators, outcomes, timing, and setting) framework, see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2014-10-27 04:21:28 -0400" MODIFIED_BY="[Empty name]">
<P>Trials comparing deep transverse friction massage versus no therapy or active treatments (such as therapeutic ultrasound, exercise program, or phonophoresis therapy) were accepted, provided they were given equally to all treatment groups. So trials comparing DTFM combined with other physical therapy manipulative interventions were excluded if co-interventions were not applied to the control group (ie, if investigators wished to assess the effects of deep massage therapy alone).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-10-26 19:24:08 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Major outcomes</HEADING>
<UL>
<LI>Mean (or mean change in) pain.</LI>
<LI>Proportion reporting pain relief of 30% or greater.</LI>
<LI>Function.</LI>
<LI>Quality of life.</LI>
<LI>Patient global assessment of success.</LI>
<LI>Total number of withdrawals due to adverse effects.</LI>
<LI>Number of adverse events.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Minor outcomes</HEADING>
<P>In addition to these outcomes, one of the review authors (LB) has developed a theoretical framework for important outcome measures for physical therapy interventions (<LINK REF="REF-Morin-1996" TYPE="REFERENCE">Morin 1996</LINK>). These outcomes were considered as secondary measures of effectiveness and include the following.</P>
<UL>
<LI>Joint range of motion (ROM).</LI>
<LI>Muscle strength (and grip strength for tendenitis of upper extremities).</LI>
<LI>Endurance.</LI>
</UL>
<P>Outcomes were assessed at end of treatment or at end of follow-up.</P>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-10-27 04:22:23 -0400" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2014-10-27 04:22:23 -0400" MODIFIED_BY="[Empty name]">
<P>We searched the specialized register of the Cochrane Field of Physical and Related Therapies, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Clinicaltrials.gov, and the Physiotherapy Evidence Database (PEDro), until July 2014 (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). The search included deep transverse friction therapy terms and tendinitis pain terms. Full strategies for these databases are provided in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> (MEDLINE), <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> (EMBASE), <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> (CENTRAL), <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK> (CINAHL), <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK> (PEDro), and <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK> (Clinicaltrials.gov).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2014-10-26 19:27:30 -0400" MODIFIED_BY="[Empty name]">
<P>We searched the reference lists of selected articles.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-10-28 13:03:02 -0400" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2014-10-27 11:12:28 -0400" MODIFIED_BY="[Empty name]">
<P>Two independent review authors (LB, LML) examined the titles and abstracts of the trials identified by the search strategy to select trials that met the inclusion criteria (see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> for more details). All trials classified as relevant by at least one of the review authors were retrieved as full-text articles and were assessed for eligibility. Disagreements were resolved by consensus. When selecting studies for inclusion, we did not consider languages other than French and English.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-10-27 11:12:32 -0400" MODIFIED_BY="[Empty name]">
<P>The results of the individual trials were extracted from the included study by two independent review authors (LB, LML) using predetermined extraction forms. Data were cross-checked by a third review author (BS). The extraction forms were developed and pilot-tested on the basis of other forms used by the Cochrane Musculoskeletal Review Group. The extraction form documented specific information about DTFM, including (1) characteristics of the technique and (2) methods of therapeutic application such as duration, frequency, rhythm, pressure, and total number of sessions. Also, forms were designed to collect information about participant characteristics (eg, age, gender, injury type, injury duration), comparator intervention characteristics, and outcomes (including scale of tool, direction of effect [eg, lower score = worse off]). Final data values were based on consensus of the two review authors. In the event of multiple time points, we would collect the last time point.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-10-27 11:12:43 -0400" MODIFIED_BY="[Empty name]">
<P>Two independent review authors (LB, LML) assessed risk of bias using the "Risk of bias" tool of The Cochrane Collaboration (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>); differences were resolved by consensus. This tool assesses seven domains: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective outcome reporting, and "other issues." For "other issues," we considered baseline imbalance as a potential source of bias. The review authors classified the different items for the two included studies as "high risk," "unclear risk," or "low risk" of bias. A third review author (BS) was consulted when necessary.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2014-10-26 19:35:50 -0400" MODIFIED_BY="[Empty name]">
<P>Mean differences (MDs) between experimental and control groups were calculated for continuous data, with the same measurements and standardized mean differences (SMDs) for continuous outcomes with different measurements, and 95% confidence intervals (CIs). For dichotomous data, risk ratios (RRs) and 95% CIs were calculated.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2014-10-26 19:36:44 -0400" MODIFIED_BY="[Empty name]">
<P>Individual participants represented the unit of analysis in these studies. No cluster-randomized controlled trials or cross-over design trials were selected. In cases of multiple treatment groups, we made multiple pairwise comparisons between all possible pairs of intervention groups to avoid double-counting of participants in the meta-analyses.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-10-26 19:37:21 -0400" MODIFIED_BY="[Empty name]">
<P>The procedure was to contact the study authors if only an abstract was provided, or if available results were not sufficient for the data analysis, or to identify additional studies. For this review update, it was not necessary to contact the study authors.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-10-28 13:03:02 -0400" MODIFIED_BY="[Empty name]">
<P>We planned to assess heterogeneity using the I<SUP>2</SUP> statistic when a value of 0% to 40% might "not be important", 30% to 60% may represent "moderate" heterogeneity, 50% to 90% may represent "substantial" heterogeneity, and 75% to 100% represents "considerable" heterogeneity (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2014-10-27 04:25:38 -0400" MODIFIED_BY="[Empty name]">
<P>We intended to assess the possibility of publication bias by using funnel plots.</P>
<P>We also planned to assess trial protocols versus published reports. For example, for studies published after July 1, 2005, we would screen the Clinical Trial Register at the International Clinical Trials Registry Platform of the World Health Organization (http://apps.who.int/trialssearch) for the a priori trial protocol. We would evaluate whether selective reporting of outcomes is present (outcome reporting bias).</P>
<P>We planned to compare the fixed-effect estimate against the random-effects model to assess the possible presence of small sample bias (ie, in which the intervention effect is more beneficial in smaller studies) in the published literature. In the presence of small sample bias, the random-effects estimate of the intervention is more beneficial than the fixed-effect estimate (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-10-26 19:39:40 -0400" MODIFIED_BY="[Empty name]">
<P>We planned to pool the intervention versus a common comparator by using the fixed-effect model of meta-analysis if data were homogenous, and the random-effects model if heterogeneity was substantive (ie, I<SUP>2 </SUP>&gt; 50%).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2014-10-26 19:39:47 -0400" MODIFIED_BY="[Empty name]">
<P>No studies were pooled; therefore exploration of heterogeneity and subgroup analyses were not possible.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-10-26 19:42:36 -0400" MODIFIED_BY="[Empty name]">
<P>We planned sensitivity analyses based on the risk of bias assessment of included studies (allocation concealment, blinding of participants, intention-to-treat analysis). However, we could not perform sensitivity analyses for this review.</P>
<SUBSECTION>
<HEADING LEVEL="3">Grading of the evidence and summary of findings tables</HEADING>
<P>We graded the overall quality of the evidence for each outcome using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach (<LINK REF="REF-Guyatt-2008" TYPE="REFERENCE">Guyatt 2008</LINK>), as recommended by The Cochrane Collaboration (<LINK REF="REF-Sch_x00fc_nemann-2011a" TYPE="REFERENCE">Schünemann 2011a</LINK>). This approach consists of four levels of quality: high, moderate, low, and very low. Evidence-based randomized studies start at a high quality rating and could be downgraded on the basis of five factors (study limitations, inconsistency of results, indirectness of evidence, imprecision, and publication bias).</P>
<P>We incorporated grading of evidence into the "Summary of findings" table. We also presented other key results in the "Summary of findings" table, as recommended by The Cochrane Collaboration (<LINK REF="REF-Sch_x00fc_nemann-2011b" TYPE="REFERENCE">Schünemann 2011b</LINK>), including the absolute and relative magnitude of effect of the interventions examined. Main outcomes in the "Summary of findings" table were mean (or mean change in) pain, proportion reporting pain relief of 30% or greater, function, quality of life, patient global assessment of success, total number of withdrawals due to adverse effects, and number of adverse events.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-10-27 11:09:08 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2014-10-27 04:27:25 -0400" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2014-10-26 19:43:21 -0400" MODIFIED_BY="[Empty name]">
<P>We retrieved 853 references after deduplication and identified 34 potentially eligible articles through electronic database searches (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). Two review authors evaluated the studies and screened 28 full-text articles on deep transverse friction massage and pain of tendinitis for eligibility. Two full-text articles met our inclusion criteria, and 26 were excluded.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-10-27 04:27:25 -0400" MODIFIED_BY="[Empty name]">
<P>Two trials met the inclusion criteria. See the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
<P>In the first included RCT (<LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>), all participants were 18 years of age or older. Mean participant age was 43.3 years, and symptom duration was 4.25 weeks. This included RCT examined the efficacy of DTFM in the management of extensor carpi radialis tendinitis (lateral elbow tendinitis or tennis elbow) and included the following comparison groups: (1) deep transverse friction massage combined with therapeutic ultrasound and placebo ointment (n = 11) versus therapeutic ultrasound combined with placebo ointment (n = 9) and (2) deep transverse friction massage and phonophoresis (n = 10) versus phonophoresis alone (n = 10). The study consisted of nine treatment sessions within five weeks.</P>
<P>The second RCT (<LINK REF="STD-Schwellnus-1992" TYPE="STUDY">Schwellnus 1992</LINK>) compared two groups: One received combined physical therapy interventions with DTFM, and the other received combined physical therapy interventions without DTFM. The study consisted of four consecutive treatment sessions in two weeks. A total of 17 participants with iliotibial band friction syndrome (lateral knee tendinitis) were randomly assigned. All participants in this study were prescribed rest, stretching exercises, cryotherapy and therapeutic ultrasound. Mean participant age was 27.6 years, disease duration was 48.5 weeks, years of running experience were 6.6, and the weekly distance in kilometers was 54.5 for both groups. Injury severity was assessed by grading the pain level (ie, grade 1: pain experienced after running; grade 2: pain experienced during running; grade 3: pain experienced during running associated with restriction of distance or velocity; grade 4: severe pain that prevents running). The grade of injury was 3.4 of a maximum possible of 4 for both groups.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-10-27 04:02:21 -0400" MODIFIED_BY="[Empty name]">
<P>Twenty-six trials were excluded for the reasons outlined here: (1) healthy participants (<LINK REF="STD-Chiarello-1997" TYPE="STUDY">Chiarello 1997</LINK>; <LINK REF="STD-Crosman-1984" TYPE="STUDY">Crosman 1984</LINK>), (2) not tendinitis (<LINK REF="STD-Balke-1989" TYPE="STUDY">Balke 1989</LINK>; <LINK REF="STD-Feehan-1989" TYPE="STUDY">Feehan 1989</LINK>; <LINK REF="STD-Thomee-1997" TYPE="STUDY">Thomee 1997</LINK>; <LINK REF="STD-Zhang-1987" TYPE="STUDY">Zhang 1987</LINK>), (3) combined modalities (<LINK REF="STD-Pellecchia-1994" TYPE="STUDY">Pellecchia 1994</LINK>), (4) combination of interventions and co-interventions not applied to the control group (<LINK REF="STD-Baltaci-2001" TYPE="STUDY">Baltaci 2001</LINK>; <LINK REF="STD-Bisset-2007" TYPE="STUDY">Bisset 2007</LINK>; <LINK REF="STD-Fernandez-2006" TYPE="STUDY">Fernandez 2006</LINK>; <LINK REF="STD-Fernandez-2008" TYPE="STUDY">Fernandez 2008</LINK>; <LINK REF="STD-Nagrale-2009" TYPE="STUDY">Nagrale 2009</LINK>; <LINK REF="STD-Smidt-2002" TYPE="STUDY">Smidt 2002</LINK>; <LINK REF="STD-Stasinopoulos-2004a" TYPE="STUDY">Stasinopoulos 2004a</LINK>; <LINK REF="STD-Stasinopoulos-2006" TYPE="STUDY">Stasinopoulos 2006</LINK>; <LINK REF="STD-Struijs-2006" TYPE="STUDY">Struijs 2006</LINK>; <LINK REF="STD-Viswas-2012" TYPE="STUDY">Viswas 2012</LINK>), (5) no control goup (<LINK REF="STD-Kohia-2008" TYPE="STUDY">Kohia 2008</LINK>; <LINK REF="STD-Malier-1986" TYPE="STUDY">Malier 1986</LINK>; <LINK REF="STD-Mayer-2007" TYPE="STUDY">Mayer 2007</LINK>; <LINK REF="STD-Stasinopoulos-2004b" TYPE="STUDY">Stasinopoulos 2004b</LINK>; <LINK REF="STD-Verhaar-1995" TYPE="STUDY">Verhaar 1995</LINK>), (6) pilot design (<LINK REF="STD-Struijs-2003" TYPE="STUDY">Struijs 2003</LINK>), and (8) not an RCT (<LINK REF="STD-Iwatsuki-2001" TYPE="STUDY">Iwatsuki 2001</LINK>; <LINK REF="STD-Joseph-2012" TYPE="STUDY">Joseph 2012</LINK>; <LINK REF="STD-Zheng-2012" TYPE="STUDY">Zheng 2012</LINK>). See the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-10-27 04:42:53 -0400" MODIFIED_BY="[Empty name]">
<P>We assessed the risk of bias for each included study using the "Risk of bias" tool of The Cochrane Collaboration. The risk of bias graph and summary are presented in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>, respectively.</P>
<ALLOCATION MODIFIED="2014-10-27 04:29:01 -0400" MODIFIED_BY="[Empty name]">
<P>In the RCT for extensor carpi radialis tendinitis (lateral elbow tendinitis) (<LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>), the study authors used a 2 × 2 factorial design and created strata on the basis of pain-free grip strength. Afterward, participants were randomly assigned to one of the four treatment groups using a balanced blocked randomization table. In the second RCT for iliotibial band friction syndrome (lateral knee tendinitis) <U>(</U>
<LINK REF="STD-Schwellnus-1992" TYPE="STUDY">Schwellnus 1992</LINK>
<U>),</U> participants were randomly assigned, but the methods of sequence generation and allocation were not described, and so risk was judged as unclear.</P>
</ALLOCATION>
<BLINDING MODIFIED="2014-10-27 04:42:53 -0400" MODIFIED_BY="[Empty name]">
<P>Participants and personnel were not blinded to treatment. As this is a physical intervention, it is more difficult to blind participants and therapists. Only the outcome assessors were blinded to the treatment groups of participants in both included studies. We did not have enough information to assess the impact on patient-reported outcomes, but detection bias is more likely "high risk" for self-reported subjective outcomes (eg, pain).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-10-26 20:10:53 -0400" MODIFIED_BY="[Empty name]">
<P>One trial (<LINK REF="STD-Schwellnus-1992" TYPE="STUDY">Schwellnus 1992</LINK>) reported a 15% dropout rate. Duration of follow-up was mentioned, but investigators did not perform an intention-to-treat analysis. In the second trial (<LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>), withdrawals and dropouts were not mentioned. However, all randomly assigned participants were accounted for in the results.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2014-10-26 20:11:10 -0400" MODIFIED_BY="[Empty name]">
<P>Both studies reported planned outcomes whether or not findings were significant (<LINK REF="STD-Schwellnus-1992" TYPE="STUDY">Schwellnus 1992</LINK>; <LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>). No protocols were found.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2014-10-27 04:03:01 -0400" MODIFIED_BY="[Empty name]">
<P>Baseline imbalance was noted in both included studies (<LINK REF="STD-Schwellnus-1992" TYPE="STUDY">Schwellnus 1992</LINK>; <LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>). The duration of symptoms, for example, was different in the intervention group compared with the control group.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-10-27 11:09:08 -0400" MODIFIED_BY="[Empty name]">
<P>No studies were pooled; therefore assessment of heterogeneity and subgroup analyses were not possible. (See <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK> section for additional details.)<BR/>
</P>
<SUBSECTION>
<HEADING LEVEL="3">Deep transverse friction masssage + therapeutic ultrasound and placebo ointment versus therapeutic ultrasound and placebo ointment</HEADING>
<P>The RCT for extensor carpi radialis tendinitis (tennis elbow) (<LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>) showed no statistically significant differences in pain intensity, grip strength, and functional status after nine consecutive sessions of deep transverse friction massage combined with therapeutic ultrasound and placebo ointment (n = 11) compared with therapeutic ultrasound alone (n = 9). We found the following: mean change in pain on a 0 to 100 visual analog scale (VAS) (MD -6.60, 95% CI -28.60 to 15.40) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>), grip strength in kilograms of force (MD 0.10, 95% CI -0.16 to 0.36) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>), function (VAS 0 to 100) (MD -1.80, 95% CI -18.64 to 15.04) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>), pain-free function index measured as the number of pain-free items (MD 1.10, 95% CI -1.00 to 3.20) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>), and functional status assessed by the physician as the number of successes needed to perform the strengthening program (RR 3.3, 95% CI 0.4 to 24.3) (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). This difference was not clinically or statistically significant. The quality of the body of evidence was "very low" according to the GRADE approach.</P>
<P>Pain-free function scores recorded in the two groups at the end of the study were -1.8 ± 2.7 for deep transverse friction massage combined with therapeutic ultrasound and placebo ointment and 2.7 ± 2.1 for therapeutic ultrasound and placebo ointment. We found the following values for the other measures, at the end of the study.</P>
<UL>
<LI>Pain VAS: 44.8 ± 33.4 for deep transverse friction massage combined with therapeutic ultrasound and placebo ointment and 23.8 ± 17.0 for therapeutic ultrasound alone.</LI>
<LI>Function VAS: 76.3 ± 21.9 for deep transverse friction massage combined with therapeutic ultrasound and placebo ointment and 78.1 ± 16.5 for therapeutic ultrasound alone.</LI>
<LI>Absolute improvement measures demonstrated reduction in pain by 7% and improvement in function by 2%.</LI>
<LI>As a minor outcome, the ratio index of pain-free grip strength scores was as follows: 0.7 ± 0.3 for deep transverse friction massage combined with therapeutic ultrasound and placebo ointment and 0.6 ± 0.3 for therapeutic ultrasound alone.</LI>
<LI>Quality of life, patient global assessment of success, adverse events, withdrawals due to adverse events, joint range of motion, and endurance were not assessed or reported. (See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Deep transverse friction masssage + phonophoresis versus phonophoresis alone</HEADING>
<P>Mean differences and risk ratios were also calculated for the comparison of deep transverse friction massage and phonophoresis (n = 10) versus phonophoresis alone (n = 10) for pain on a 0 to 100 VAS scale (MD -1.2, 95% CI -20.24 to 17.84) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>), grip strength in kilograms of force (MD -0.20; 95% CI -0.46 to 0.06) (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>), function (VAS 0 to 100) (MD 3.70, 95% CI -14.13 to 21.53) (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>), pain-free function index measured as the number of pain-free items (MD 0.10, 95% CI -2.27 to 2.47) (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>), and functional status assessed by the physician as the number of successes needed to perform the strengthening program (RR 0.67, 95% CI 0.1 to 3.2) (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>) in extensor carpi radialis tendinitis (<LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>). This difference was not clinically or statistically significant. Again, the quality of the body of evidence received a score of "very low" according to the GRADE approach.</P>
<P>The study authors reported different results for the two groups for pain-free function scores, at the end of the study: 3.7 ± 2.8 for deep transverse friction massage and phonophoresis compared with 3.6 ± 2.6 for phonophoresis alone.</P>
<UL>
<LI>Pain VAS: 24.6 ± 20.6 for deep transverse friction massage and phonophoresis compared with 21.8 ± 30.4 for phonophoresis alone.</LI>
<LI>Function VAS: 82.5 ± 16.3 for deep transverse friction massage and phonophoresis compared with 78.8 ± 23.7 for phonophoresis alone.</LI>
<LI>Absolute improvement confirmed reduction in pain by 1% and improvement in function by 4%.</LI>
</UL>
<UL>
<LI>As a minor outcome, results for the ratio index of pain-free grip strength were as follows: 0.5 ± 0.3 for deep transverse friction massage and phonophoresis compared with 0.7 ± 0.3 for phonophoresis alone.</LI>
<LI>Proportion reporting pain relief of 30% or greater, quality of life, patient global assessment of success, adverse events, withdrawals due to adverse events, joint range of motion, and endurance were not assessed or reported. (See <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>.)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Deep transverse friction masssage and physical therapy versus physical therapy alone</HEADING>
<P>Only one small study with 17 participants looked at this comparison in iliotibial band friction syndrome (knee tendinitis) (<LINK REF="STD-Schwellnus-1992" TYPE="STUDY">Schwellnus 1992</LINK>). Although within-group reduction in the three types of pain relief measured was significant (overall daily pain, pain while running, and percentage of maximum pain when running) on a 0 to 10 VAS scale, in both treatment groups after two weeks of follow-up (P value &lt; 0.0005), no statistically significant between-group differences (mean differences (MDs)) were reported for daily pain (MD -0.40, 95% CI -0.80 to 0.00), pain while running measured as the total daily pain of all participants while running (scale from 0 to 150) (MD -3.00, 95% CI -11.08 to 5.08), and percentage of maximum pain while running (MD -0.10, 95% CI -3.97 to 3.77) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). The absolute improvement highlighted a reduction in pain by 4%. It is important to note that the difference in daily pain was significant at P value 0.05 in favor of DTFM, although care in assessing this result must be exercised, as (1) the result is borderline significant and (2) the data are determined from a graph and are subject to interpretation errors. In addition, the quality of the body of evidence according to the GRADE approach received a score of "very low."</P>
<UL>
<LI>Mean daily pain scores recorded in the two groups, at the end of the study, were as follows: 0.6 ± 0.3 for the experimental group (combined physiotherapy interventions and DTFM) and 1 ± 0.5 for the control group (physiotherapy interventions only).</LI>
<LI>At the same period, the study authors found different results in the two groups for total pain while running: 20 ± 9 for the experimental group and 23 ± 8 for the control group.</LI>
<LI>Finally, the percentage of maximum pain experienced during running for the two groups was similar at the end of the study: 8 ± 5 for the experimental group and 8.1 ± 3 for the control group.</LI>
<LI>Proportion reporting pain relief of 30% or greater, function, quality of life, patient global assessment of success, number of adverse effects, total number of withdrawals due to adverse effects, joint range of motion, muscle strength, and endurance were not mentioned or reported. (See <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK>.)</LI>
</UL>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-10-27 04:40:02 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2014-10-26 20:27:28 -0400" MODIFIED_BY="[Empty name]">
<P>Evidence was insufficient to demonstrate a consistent clinically important benefit of deep transverse friction massage combined with additional physical therapy modalities when compared with a control in the treatment of extensor carpi radialis tendinitis (lateral elbow tendinitis) (<LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>) and of iliotibial band friction syndrome (knee tendinitis) (<LINK REF="STD-Schwellnus-1992" TYPE="STUDY">Schwellnus 1992</LINK>). The additional benefit of deep transverse friction massage was not confirmed, as combined interventions were used. The included studies did not report on adverse events.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-10-26 20:29:06 -0400" MODIFIED_BY="[Empty name]">
<P>Only two clinical trials met the inclusion criteria of this review update. Moreover, these two trials were at high risk of bias. Therefore evidence on the specific benefits of deep transverse friction massage is sparse. Further, results of the intervention looking at deep transverse friction massage and physical therapy versus physical therapy alone may not be applicable to general populations, as participants in the trial were experienced runners. The Philadelphia Panel recommends that evidence is insufficient (level 1, grade C for pain) to include or exclude deep transverse friction massage alone as a therapeutic intervention for treating tendinitis (<LINK REF="REF-Philadelphia-2001" TYPE="REFERENCE">Philadelphia 2001</LINK>). Evaluation of deep transverse friction massage as a single treatment in comparison with other techniques has not been undertaken, so its efficacy has not yet been demonstrated (<LINK REF="STD-Joseph-2012" TYPE="STUDY">Joseph 2012</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-10-27 04:36:39 -0400" MODIFIED_BY="[Empty name]">
<P>For both included RCTs, the two major outcomes (pain and function) received a GRADE score of &#8220;very low&#8221; for the quality of the body of evidence.</P>
<P>The two RCTs included in this systematic review highlight a common problem among trials of rehabilitation interventions: difficulty or inability to blind participants and personnel, which contributes to the high risk of bias. Although outcome assessors were blinded in both studies, lack of blinding of participants may have an impact on patient-reported outcomes such as pain, leading to overestimation. Both presented baseline imbalance (mean age and duration of symptoms were different across groups). One of the studies (<LINK REF="STD-Schwellnus-1992" TYPE="STUDY">Schwellnus 1992</LINK>) demonstrated high risk of incomplete outcome data, as investigators reported a 15% dropout rate, and no intention-to-treat analysis was performed. The small sample sizes and wide confidence intervals also contribute to the very low quality rating of the body of evidence for reported outcomes.</P>
<P>Confounding variables such as characteristics of the device, characteristics of the therapeutic application, characteristics of the population, characteristics of the disease, and methodological considerations might have contributed to the lack of effect (<LINK REF="REF-Morin-1996" TYPE="REFERENCE">Morin 1996</LINK>). Characteristics of the technique described by Cyriax (<LINK REF="REF-Cyriax-1975a" TYPE="REFERENCE">Cyriax 1975a</LINK>; <LINK REF="REF-Cyriax-1975b" TYPE="REFERENCE">Cyriax 1975b</LINK>) such as years of experience of the therapist, characteristics of the application (pressure, rhythm and progression, and frequency), duration of treatment sessions and the treatment schedule, characteristics of the population (age, gender), characteristics of the disease (chronic vs acute conditions), and weakness of methodological considerations (comparison groups, sample size, study duration, nonvalidated outcome measures) in both studies (<LINK REF="STD-Schwellnus-1992" TYPE="STUDY">Schwellnus 1992</LINK>; <LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>) may have contributed to inconclusive results on the effectiveness of deep transverse friction massage for tendinitis. FInally, larger and better powered studies are required to confirm findings because of the small number of studies included in this update of the review and the small sample sizes presented by the included trials.</P>
<P>For both studies, further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. In other words, we obtained very low grades for the main outcomes, principally because of unclear allocation concealment and randomization, single-blind processes, wide confidence intervals, and small sample size.<BR/>
</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2014-10-27 04:37:15 -0400" MODIFIED_BY="[Empty name]">
<P>It is important to consider whether all relevant trials were identified (whether or not all pertinent data could be obtained) and if the methods used (search strategy, selection of studies, data collection, analysis) could have introduced potential bias. When selecting studies for inclusion, we did not consider languages other than French and English. This could have limited the number of potentially eligible studies found.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2014-10-27 04:40:02 -0400" MODIFIED_BY="[Empty name]">
<P>This systematic review of deep transverse friction massage for tendinitis was initially conducted as part of a guideline development project entitled the Philadelphia Panel Guidelines on Rehabilitation Interventions for knee pain (<LINK REF="REF-Philadelphia-2001" TYPE="REFERENCE">Philadelphia 2001</LINK>). Other guidelines such as <LINK REF="REF-ACR-1996" TYPE="REFERENCE">ACR 1996</LINK>, <LINK REF="REF-ACR-2000" TYPE="REFERENCE">ACR 2000</LINK>, <LINK REF="REF-Godlee-2000" TYPE="REFERENCE">Godlee 2000</LINK>, and <LINK REF="REF-Manal-1996" TYPE="REFERENCE">Manal 1996</LINK> did not evaluate any type of massage as a treatment intervention for knee conditions. To our knowledge, no guidelines on massage for extensor carpi radialis tendinitis are available. The American Physical Therapy Association (APTA) guidelines (<LINK REF="REF-APTA-2001" TYPE="REFERENCE">APTA 2001</LINK>) recommend massage for musculoskeletal conditions, although the APTA guidelines do not differentiate between types of massage. However, these guidelines are not based on evidence from comparative controlled trials.</P>
<P>No meta-analysis or literature reviews have reported the efficacy of this type of massage (<LINK REF="REF-Chapman-1991" TYPE="REFERENCE">Chapman 1991</LINK>; <LINK REF="REF-Furlan-2008" TYPE="REFERENCE">Furlan 2008</LINK>; <LINK REF="REF-Green-1998" TYPE="REFERENCE">Green 1998</LINK>; <LINK REF="REF-van-der-Heijden-1997" TYPE="REFERENCE">van der Heijden 1997</LINK>). Evaluation of deep transverse friction massage as a single treatment in comparison with other techniques has not been undertaken, so its efficacy has not been yet demonstrated. Comparison of different studies is difficult to perform because of heterogeneity in terms of (1) types of tendinitis, (2) confounding approaches, and (3) varied outcome measures selected (<LINK REF="STD-Joseph-2012" TYPE="STUDY">Joseph 2012</LINK>).</P>
<P>In the included RCT (<LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>), deep transverse friction massage was performed to reduce symptoms of tendinitis. The inflammation and pain observed in tendinitis are frequently due to three main factors: (1) biomechanical factors), (2) anthropometric factors, and (3) training factors. Pain is an indirect symptom. Based on identified factors, pain could be controlled more effectively through other physical therapy interventions such as strengthening and postural exercises, or changes in functional and sporting activities that correct biomechanical deficiencies (<LINK REF="REF-Thaunton-1987" TYPE="REFERENCE">Thaunton 1987</LINK>), restore motion (<LINK REF="REF-Hart-1994" TYPE="REFERENCE">Hart 1994</LINK>), increase strength, endurance, and function (<LINK REF="REF-Hart-1994" TYPE="REFERENCE">Hart 1994</LINK>; <LINK REF="REF-Thaunton-1987" TYPE="REFERENCE">Thaunton 1987</LINK>), and permit gradual return to training (<LINK REF="REF-Thaunton-1987" TYPE="REFERENCE">Thaunton 1987</LINK>). One included study (<LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>) found that phonophoresis is not superior to ultrasound and placebo ointment, where similar results were obtained. Antich et al (<LINK REF="REF-Antich-1986" TYPE="REFERENCE">Antich 1986</LINK>) mentioned that phonophoresis is as good as ice and ultrasound. Halle and colleagues (<LINK REF="REF-Halle-1986" TYPE="REFERENCE">Halle 1986</LINK>) confirmed that ultrasound, transcutaneous electrical nerve stimulation (TENS), and cortisone injections represent comparative therapies in terms of efficacy. The second included RCT (<LINK REF="STD-Schwellnus-1992" TYPE="STUDY">Schwellnus 1992</LINK>) suggested that the addition of deep transverse friction massage might not appear to aggravate clinical outcomes in iliotibial band friction syndrome (knee tendinitis). Therefore, the included study rejected the findings of the first study author, who examined the biologic rationale of this therapy (<LINK REF="REF-Griffin-1963" TYPE="REFERENCE">Griffin 1963</LINK>) and reported that the success rate was significantly greater in the phonophoresis group compared with the group given ultrasound therapy. Similar success rates for the phonophoresis groups were shown in the work of Kleinkort et al (Griffin 62% vs Kleinkort 66%) (<LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>). However, it is important to note that those study authors did not consider the presence of potential confounding variables, and neither of them reported their diagnostic criteria and the power of their statistical test (<LINK REF="STD-Stratford-1989" TYPE="STUDY">Stratford 1989</LINK>).</P>
<P>Additional well-designed RCTs are needed before this specific type of massage can be excluded for treatment of this condition. Clinicians and patients need to be presented with evidence that will enable them to make informed decisions regarding treatment options.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-10-27 04:40:39 -0400" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-10-27 04:40:39 -0400" MODIFIED_BY="[Empty name]">
<P>Evidence was insufficient to reveal the clinically important benefit of deep transverse friction massage (DTFM) in treating tendinitis. Unfortunately, almost no persuasive scientific research about DTFM has been reported. The therapeutic approach consists mainly of reasonable speculation about biology, as the effects of DTFM are based on sound physiologic and pathologic theories. In other words, many patients respond well to any kind of stimulation techniques that may alter a chronically painful condition. Even though the technique seems to work well in practice, the absence of evidence remains a matter of primary concern, as the use of DTFM must absolutely be supported by clinical evidence. Therefore, it is clear that better designed studies are needed before conclusions can be drawn about the efficacy or lack of efficacy of deep transverse friction massage for treating symptomatic tendinitis (<LINK REF="STD-Joseph-2012" TYPE="STUDY">Joseph 2012</LINK>).</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-10-26 20:42:56 -0400" MODIFIED_BY="[Empty name]">
<P>To justify the use of deep transverse friction massage in the treatment of tendinitis, large, high-quality randomized trials using validated outcome measures and high-quality reporting methods are needed.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-10-28 08:07:46 -0400" MODIFIED_BY="[Empty name]">
<P>The review authors thank Lisa Levesque, Shaïman Gibeault, Judith Robitaille, Michel Boudreau, Michael Saginur, and Sarah Clément for help with data extraction and literature retrieval, as well as the editorial team of the Cochrane Musculoskeletal Review Group for valuable comments on early drafts.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2014-10-28 08:04:02 -0400" MODIFIED_BY="[Empty name]">
<P>All the authors have no conflict of interest to declare.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-10-28 08:04:54 -0400" MODIFIED_BY="[Empty name]">
<P>LB and LML were responsible for writing the manuscript, extracting and analyzing data, and selecting trials for the initial review.</P>
<P>LML, PR and GDA performed data extraction and updated selections from the reference list, the analyses, and the interpretation of results.</P>
<P>PR was responsible for the literature search update.</P>
<P>BS, PT, GW, VW and SP contributed methodological expertise and commented on early drafts.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-10-26 20:47:32 -0400" MODIFIED_BY="[Empty name]">
<P>We used the "Risk of bias" tool to assess the risk of bias in included studies and presented the results in "Summary of findings" tables.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-10-28 13:07:21 -0400" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2014-10-27 04:46:44 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2014-10-27 03:43:13 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Schwellnus-1992" MODIFIED="2014-10-27 03:43:13 -0400" MODIFIED_BY="[Empty name]" NAME="Schwellnus 1992" YEAR="1992">
<REFERENCE MODIFIED="2014-10-27 03:43:13 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwellnus MP, Mackintosh L, Mee J</AU>
<TI>Deep transverse frictions in the treatment of iliotibial band friction syndrome in athletes: a clinical trial</TI>
<SO>Physiotherapy</SO>
<YR>1992</YR>
<VL>78</VL>
<NO>8</NO>
<PG>564-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-02-19 11:58:45 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stratford-1989" MODIFIED="2013-02-19 11:25:15 -0500" MODIFIED_BY="[Empty name]" NAME="Stratford 1989" YEAR="1989">
<REFERENCE MODIFIED="2013-02-19 11:25:15 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stratford PW, Levy DR, Gauldie S, Miseferi D, Levy K</AU>
<TI>The evaluation of phonophoresis and friction massage as treatments for extensor carpi radialis tendinitis: a randomized controlled trial</TI>
<SO>Physiotherapy Canada</SO>
<YR>1989</YR>
<VL>41</VL>
<NO>2</NO>
<PG>93-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-10-27 04:46:44 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Balke-1989" MODIFIED="2013-02-19 11:58:33 -0500" MODIFIED_BY="[Empty name]" NAME="Balke 1989" YEAR="1989">
<REFERENCE MODIFIED="2013-02-19 11:58:33 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Balke B, Anthony J, Wyatt F. The effects of massage treatment on exercise fatigue. Clinical Sports Medicine 1989, Vol 1: pp189-196. *Not tendinitis&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:58:33 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Balke B, Anthony J, Wyatt F</AU>
<TI>The effects of massage treatment on exercise fatigue</TI>
<SO>Clinical Sports Medicine</SO>
<YR>1989</YR>
<VL>1</VL>
<PG>189-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baltaci-2001" MODIFIED="2013-02-19 16:31:00 -0500" MODIFIED_BY="[Empty name]" NAME="Baltaci 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-02-19 16:31:00 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baltaci G, Ergun N, Tunay VB</AU>
<TI>Effectiveness of Cyriax manipulative therapy and elbow band in the treatment of lateral epicondylitis</TI>
<SO>European Journal of Sports Traumatology and Related Research</SO>
<YR>2001</YR>
<VL>23</VL>
<NO>3</NO>
<PG>113-8</PG>
<IDENTIFIERS MODIFIED="2013-02-19 11:26:31 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bisset-2007" MODIFIED="2014-10-27 03:43:58 -0400" MODIFIED_BY="[Empty name]" NAME="Bisset 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-10-27 03:43:58 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bisset L, Smidt N, Van der Windt DA, Bouter LM, Jull G, Brooks P, et al</AU>
<TI>Conservative treatments for tennis elbow&#8212;do subgroups of patients respond differently?</TI>
<SO>Rheumatology</SO>
<YR>2007</YR>
<VL>1</VL>
<PG>1601-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chiarello-1997" MODIFIED="2013-02-19 11:29:21 -0500" MODIFIED_BY="[Empty name]" NAME="Chiarello 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-06-09 08:57:33 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Chiarello CM, Gundersen L, O'Halloran T. The effect of continuous passive motion duration and increment on range of motion in total knee arthroplasty patients. Journal of Orthopaedic &amp;amp; Sports Physical Therapy 1997; 25(2):119-127. *RCT of healthy subjects- effects of massage on stretch reflex&lt;/p&gt;" NOTES_MODIFIED="2010-06-09 08:57:33 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chiarello CM, Gundersen L, O'Halloran T</AU>
<TI>The effect of continuous passive motion duration and increment on range of motion in total knee arthroplasty patients</TI>
<SO>Journal of Orthopaedic &amp; Sports Physical Therapy</SO>
<YR>1997</YR>
<VL>25</VL>
<NO>2</NO>
<PG>119-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Crosman-1984" MODIFIED="2013-02-19 11:58:24 -0500" MODIFIED_BY="[Empty name]" NAME="Crosman 1984" YEAR="1984">
<REFERENCE MODIFIED="2013-02-19 11:58:24 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Crosman LJ, Chateauvert SR, Weisberg J. The effects of massage to the hamstring muscle group on range of motion. J Orthop Sport Phys Ther 1984; 6:168-172. *RCT of massage on hamstring range of motion in healthy normal subjects&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:58:24 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Crosman LJ, Chateauvert SR, Weisberg J</AU>
<TI>The effects of massage to the hamstring muscle group on range of motion</TI>
<SO>Journal of Orthopaedic and Sports Physical Therapy</SO>
<YR>1984</YR>
<VL>6</VL>
<PG>168-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feehan-1989" MODIFIED="2010-07-06 11:34:59 -0400" MODIFIED_BY="[Empty name]" NAME="Feehan 1989" YEAR="1989">
<REFERENCE MODIFIED="2010-07-06 11:34:59 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Feehan RC. The efficacy of using transverse friction massage on improving active and passive range of motion in the client with chronic knee dysfunction. THE UNION INSTITUTE ** 1989;(64 p). *CCT of massage on range of motion of people with &amp;quot;chronic knee dysfunction&amp;quot;- not tendinitis&lt;/p&gt;" NOTES_MODIFIED="2010-07-06 11:34:59 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feehan RC</AU>
<TI>The efficacy of using transverse friction massage on improving active and passive range of motion in the client with chronic knee dysfunction</TI>
<SO>The Union Institute</SO>
<YR>1989</YR>
<VL>51(3)</VL>
<PG>64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandez-2006" MODIFIED="2013-02-19 11:35:08 -0500" MODIFIED_BY="[Empty name]" NAME="Fernandez 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-02-19 11:30:28 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernández-de-las-Penas C, Alonso-Blanco C, Fernandez-Carnero J, Miangolarr-Page J</AU>
<TI>The immediate effect of ischemic compression technique and transverse friction massage on tenderness of active and latent myofascial trigger points: a pilot study</TI>
<SO>Journal of Bodywork and Movement Therapies</SO>
<YR>2006</YR>
<VL>10</VL>
<PG>807-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandez-2008" MODIFIED="2014-09-17 15:40:00 -0400" MODIFIED_BY="[Empty name]" NAME="Fernandez 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-09-17 15:40:00 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernández-Pérez AM, Peralta-Ramírez MI, Pilat A, Villaverde C</AU>
<TI>Effects of myofascial induction techniques on physiologic and psychologic parameters: a randomized controlled trial</TI>
<SO>The Journal of Alternative and Complementary Medicine</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>7</NO>
<PG>807-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Iwatsuki-2001" MODIFIED="2014-09-17 15:41:49 -0400" MODIFIED_BY="[Empty name]" NAME="Iwatsuki 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-09-17 15:41:49 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Iwatsuki H, Ikuta Y, Shinoda K</AU>
<TI>Deep friction massage on the masticatory muscles in stroke patients increases biting force</TI>
<SO>Journal of Physical Therapy Science</SO>
<YR>2001</YR>
<VL>13</VL>
<NO>1</NO>
<PG>17-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Joseph-2012" MODIFIED="2014-09-17 15:41:37 -0400" MODIFIED_BY="[Empty name]" NAME="Joseph 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-09-17 15:41:37 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Joseph MF, Taft K, Moskwa M</AU>
<TI>Deep friction massage to treat tendinopathy: a systematic review of a classic treatment in the face of a new paradigm of understanding</TI>
<SO>Journal of Sports Rehabilitation</SO>
<YR>2012</YR>
<VL>21</VL>
<NO>4</NO>
<PG>343-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kohia-2008" MODIFIED="2013-02-19 11:33:33 -0500" MODIFIED_BY="[Empty name]" NAME="Kohia 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-02-19 11:33:33 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kohia M, Brackle J, Byrd K, Jennings A, Murray W, Wilfong E</AU>
<TI>Effectiveness of physical therapy treatment on lateral epicondylitis</TI>
<SO>Journal of Sport Rehabilitation</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>2</NO>
<PG>119-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malier-1986" MODIFIED="2014-10-27 03:45:00 -0400" MODIFIED_BY="[Empty name]" NAME="Malier 1986" YEAR="1986">
<REFERENCE MODIFIED="2014-10-27 03:45:00 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malier M, Troisier O</AU>
<TI>Deep transverse massage for the treatment of tennis elbow</TI>
<TO>La place du massage transversal profond dans le traitement des tendinites épicondyliennes: à propos de 131 cas</TO>
<SO>Annales de Réadaptation et de Médecine Physique</SO>
<YR>1986</YR>
<VL>29</VL>
<PG>75-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mayer-2007" MODIFIED="2014-10-27 03:45:18 -0400" MODIFIED_BY="[Empty name]" NAME="Mayer 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-10-27 03:45:18 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mayer F, Hirschmuller A, Muller S, et al</AU>
<TI>Effect of short-term treatment strategies over 4 weeks in Achilles tendinopathy</TI>
<SO>British Journal of Sport Medecine</SO>
<YR>2007</YR>
<VL>41</VL>
<NO>7</NO>
<PG>e6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nagrale-2009" MODIFIED="2013-04-18 10:50:14 -0400" MODIFIED_BY="[Empty name]" NAME="Nagrale 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-04-18 10:50:14 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nagrale AV, Herd CR, Ganvir S, Ramteke G</AU>
<TI>Cyriax physical therapy versus phonophoresis with supervised exercise in subjects with lateral epicondylalgia: a randomized clinical trial</TI>
<SO>Journal of Manual and Manipulative Therapy</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>3</NO>
<PG>171-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pellecchia-1994" MODIFIED="2013-02-19 11:58:16 -0500" MODIFIED_BY="[Empty name]" NAME="Pellecchia 1994" YEAR="1994">
<REFERENCE MODIFIED="2013-02-19 11:58:16 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Pellecchia GL, Hamel H, Behnke P. Treatment of infrapatellar tendinitis: a combination of modalities and transverse friction massage versus iontophoresis. Journal of Sport Rehabilitation 1994; 3(2):135-145. *RCT of combined modalities (including ultrasound) versus iontophoresis for patellar tendinitis- exclude since effect of ultrasound cannot be separated from the other modalities&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:58:16 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pellecchia GL, Hamel H, Behnke P</AU>
<TI>Treatment of infrapatellar tendinitis: a combination of modalities and transverse friction massage versus iontophoresis</TI>
<SO>Journal of Sport Rehabilitation</SO>
<YR>1994</YR>
<VL>3</VL>
<NO>2</NO>
<PG>135-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smidt-2002" MODIFIED="2013-04-18 10:50:14 -0400" MODIFIED_BY="[Empty name]" NAME="Smidt 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-04-18 10:50:14 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smidt N, Van der Windt DA, Assendelft WJJ, Devillé WL, Korthals-de Bos IB, Bouter LM</AU>
<TI>Corticosteroid injections, physical therapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial</TI>
<SO>The Lancet</SO>
<YR>2002</YR>
<VL>359</VL>
<PG>657-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stasinopoulos-2004a" MODIFIED="2013-04-18 10:50:14 -0400" MODIFIED_BY="[Empty name]" NAME="Stasinopoulos 2004a" YEAR="2004">
<REFERENCE MODIFIED="2013-04-18 10:50:14 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stasinopoulos D, Johnson MI</AU>
<TI>Curiax physical therapy for tennis elbow/lateral epicondylitis</TI>
<SO>British Journal of Sport Medecine</SO>
<YR>2004</YR>
<VL>38</VL>
<NO>6</NO>
<PG>675-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-02-19 11:45:22 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stasinopoulos-2004b" MODIFIED="2013-12-03 14:01:27 -0500" MODIFIED_BY="[Empty name]" NAME="Stasinopoulos 2004b" YEAR="2004">
<REFERENCE MODIFIED="2013-02-19 11:46:10 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stasinopoulos D, Stasinopoulos I</AU>
<TI>Comparison of effective exercise programme, pulsed ultrasound and transverse friction in the treatment of chronic patellar tendinopathy</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>4</NO>
<PG>347-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stasinopoulos-2006" MODIFIED="2014-10-27 04:46:44 -0400" MODIFIED_BY="[Empty name]" NAME="Stasinopoulos 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-10-27 04:46:44 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stasinopoulos D, Stasinopoulos I</AU>
<TI>Comparison of effects of Cyriax physical therapy, a supervised exercise program and polarized polychromatic non-coherent light (Bioptron light) for the treatment of lateral epicondylitis</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2006</YR>
<VL>20</VL>
<NO>1</NO>
<PG>12-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Struijs-2003" MODIFIED="2013-02-19 11:47:43 -0500" MODIFIED_BY="[Empty name]" NAME="Struijs 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-02-19 11:47:43 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Struijs P, Damen PJ, Bakker E, Blankevoort L, Assendelft WJ, van Dijk CN</AU>
<TI>Manipulation of the wrist for management of lateral epicondylitis: a randomized pilot study</TI>
<SO>Physical Therapy</SO>
<YR>2003</YR>
<VL>83</VL>
<NO>7</NO>
<PG>608-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Struijs-2006" MODIFIED="2013-04-18 10:50:14 -0400" MODIFIED_BY="[Empty name]" NAME="Struijs 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-04-18 10:50:14 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Struijs P, Korthals-de Bos I, van Tudler M, van Dijk CN, Bouter LM, Assendelft WJ</AU>
<TI>Cost effectiveness of brace, physical therapy, or both for treatment of tennis elbow</TI>
<SO>British Journal of Sports Medecine</SO>
<YR>2006</YR>
<VL>40</VL>
<PG>637-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thomee-1997" MODIFIED="2013-02-19 11:50:03 -0500" MODIFIED_BY="[Empty name]" NAME="Thomee 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-02-19 11:50:03 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Thomee R. A comprehensive treatment approach for patellofemoral pain syndrome in young women. Physical Therapy 1997 Dec;77(12):1690-703. * Not massage&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:50:03 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thomee RA</AU>
<TI>A comprehensive treatment approach for patellofemoral pain syndrome in young women</TI>
<SO>Physical Therapy</SO>
<YR>1997</YR>
<VL>77</VL>
<NO>12</NO>
<PG>1690-703</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Verhaar-1995" MODIFIED="2014-10-27 03:46:36 -0400" MODIFIED_BY="[Empty name]" NAME="Verhaar 1995" YEAR="1995">
<REFERENCE MODIFIED="2014-10-27 03:46:36 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Verhaar JAN, Walenkamp GH, van Mameren H, Kester AD, van der Linden AJ</AU>
<TI>Local corticosteroid injection versus Cyriax-type physical therapy for tennis elbow</TI>
<SO>Journal of Bone and Joint Surgery [British Volume]</SO>
<YR>1995</YR>
<VL>77</VL>
<PG>128-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Viswas-2012" MODIFIED="2014-10-27 03:47:26 -0400" MODIFIED_BY="[Empty name]" NAME="Viswas 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-10-27 03:47:26 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Viswas R, Ramachandran R, Anantkumar P</AU>
<TI>Comparison of effectiveness of supervised exercise program and Cyriax physiotherapy in patients with tennis elbow (lateral epicondylitis): a randomized clinical trial</TI>
<SO>Scientific World Journal</SO>
<YR>2012</YR>
<VL>doi:10.1100/2012/939645</VL>
<IDENTIFIERS MODIFIED="2014-09-17 15:25:33 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-1987" MODIFIED="2014-09-01 23:22:58 -0400" MODIFIED_BY="[Empty name]" NAME="Zhang 1987" YEAR="1987">
<REFERENCE MODIFIED="2014-09-01 23:22:58 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Zhang ZB, Carter RM, Minikin BR, Telford RD. The influence of repeated massage on leg strength. Australian Institute of Sport Canberra, 1987, 5 p. *Not an RCT or CCT&lt;/p&gt;" NOTES_MODIFIED="2014-09-01 23:22:58 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang ZB, Carter RM, Minikin BR, Telford RD</AU>
<TI>The influence of repeated massage on leg strength</TI>
<SO>Australian Institute of Sport Canberra</SO>
<YR>1987</YR>
<VL>5</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zheng-2012" MODIFIED="2014-10-27 03:47:54 -0400" MODIFIED_BY="[Empty name]" NAME="Zheng 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-10-27 03:47:54 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zheng Z, Wang J, Gao Q, Hou J, Ma L, Jiang C, Chen G</AU>
<TI>Therapeutic evaluation of lumbar tender point deep massage for chronic non-specific low back pain</TI>
<SO>Journal of Traditional Chinese Medicine</SO>
<YR>2014</YR>
<VL>32</VL>
<NO>4</NO>
<PG>534-7</PG>
<IDENTIFIERS MODIFIED="2014-09-28 15:11:48 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-09-28 15:11:31 -0400" MODIFIED_BY="[Empty name]"/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-10-28 13:07:21 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2014-10-28 13:07:21 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-ACR-1996" MODIFIED="2014-10-27 03:48:15 -0400" MODIFIED_BY="[Empty name]" NAME="ACR 1996" NOTES="&lt;p&gt;ACR: American College of Rheumatology Ad Hoc Committee on Clinical Guidelines: Guidelines for the management of Rheumatoid arthritis. Arthritis and Rheumatism 39: 713-722, 1996.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2014-10-27 03:48:15 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>American College of Rheumatology Ad Hoc Committee on Clinical Guidelines</AU>
<TI>Guidelines for the management of rheumatoid arthritis</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>1996</YR>
<VL>39</VL>
<PG>713-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ACR-2000" MODIFIED="2013-02-19 10:06:33 -0500" MODIFIED_BY="[Empty name]" NAME="ACR 2000" NOTES="&lt;p&gt;ACR: American College of Rheumatology  Subcommittee on Osteoarthritis Guidelines:  Recommendations for the medical management of  osteoarthritis of the hip and knee. Arthritis and Rheumatism 43: 1905-1915, 2000.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 10:06:33 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>ACR: American College of Rheumatology Subcommittee on Osteoarthritis Guidelines</AU>
<TI>Recommendations for the medical management of osteoarthritis of the hip and knee</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>2000</YR>
<VL>43</VL>
<PG>1905-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Allander-1974" MODIFIED="2013-02-19 10:06:47 -0500" MODIFIED_BY="[Empty name]" NAME="Allander 1974" NOTES="&lt;p&gt;Allander E. Prevalence, incidence and remission rates of some common rheumatic diseases or syndromes. Scandinavian Journal of Rheumatology 1974; 3: 145-153.&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 10:06:47 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Allander E</AU>
<TI>Prevalence, incidence and remission rates of some common rheumatic diseases or syndromes</TI>
<SO>Scandinavian Journal of Rheumatology</SO>
<YR>1974</YR>
<VL>3</VL>
<PG>145-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Antich-1986" MODIFIED="2014-10-27 03:48:44 -0400" MODIFIED_BY="[Empty name]" NAME="Antich 1986" TYPE="JOURNAL_ARTICLE">
<AU>Antich TJ, Randall CC, Westbrook RA, et al</AU>
<TI>Physical therapy treatment of knee mechanism disorders: comparison of four treatment modalities</TI>
<SO>Journal of Orthopaedic and Sports Physical Therapy</SO>
<YR>1986</YR>
<VL>8</VL>
<PG>255-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APTA-2001" NAME="APTA 2001" NOTES="&lt;p&gt;Guide to Physical Therapist Practice:  Part One:  A Description of Patient/Client Management.  Alexandria, Va:  American Physical Therapy Association; 2001.&lt;/p&gt;" TYPE="BOOK">
<AU>American Physical Therapy Association</AU>
<SO>Guide to Physical Therapist Practice: Part One: A Description of Patient/Client Management</SO>
<YR>2001</YR>
<PB>American Physical Therapy Association</PB>
<CY>Alexandria, Va</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chapman-1991" MODIFIED="2013-02-19 10:21:34 -0500" MODIFIED_BY="[Empty name]" NAME="Chapman 1991" NOTES="&lt;p&gt;Chapman CE. Can the use of physical modalities for pain control be rationalized by the research evidence? Can J Physiol Pharmacol 69:704-712, 1991.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 10:21:34 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Chapman CE</AU>
<TI>Can the use of physical modalities for pain control be rationalized by the research evidence?</TI>
<SO>Canadian Journal of Physiology and Pharmacology</SO>
<YR>1991</YR>
<VL>69</VL>
<PG>704-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cyriax-1975a" MODIFIED="2011-05-18 15:17:16 -0400" MODIFIED_BY="[Empty name]" NAME="Cyriax 1975a" NOTES="&lt;p&gt;Cyriax J. Diagnosis of soft tissue lesions. Textbook of Orthopaedic Medicine. Vol 1, 9th edition. Baltimore, Williams and Wilkins, 1975.&lt;/p&gt;" NOTES_MODIFIED="2011-05-18 15:17:16 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="BOOK_SECTION">
<AU>Cyriax J</AU>
<TI>Diagnosis of soft tissue lesions</TI>
<SO>Textbook of Orthopaedic Medicine</SO>
<YR>1975</YR>
<VL>1</VL>
<EN>9th</EN>
<ED>Cyriax J</ED>
<PB>Williams and Wilkins</PB>
<CY>Baltimore</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cyriax-1975b" MODIFIED="2011-05-18 15:17:33 -0400" MODIFIED_BY="[Empty name]" NAME="Cyriax 1975b" NOTES="&lt;p&gt;Cyriax J. Diagnosis of soft tissue lesions. Textbook of Orthopaedic Medicine. Vol 1, 9th edition. Baltimore, Williams and Wilkins, 1975.&lt;/p&gt;" NOTES_MODIFIED="2011-05-18 15:17:33 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="BOOK_SECTION">
<AU>Cyriax J</AU>
<TI>Treatment by manipulation, massage and injection</TI>
<SO>Textbook of Orthopaedic Medicine</SO>
<YR>1975</YR>
<VL>2</VL>
<EN>9th</EN>
<ED>Cyriax J</ED>
<PB>Williams and Wilkins</PB>
<CY>Baltimore</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furlan-2008" MODIFIED="2014-10-27 03:49:21 -0400" MODIFIED_BY="[Empty name]" NAME="Furlan 2008" NOTES="&lt;p&gt;Furlan AD, Brosseau L., Robinson V., Irvin E., Imamura M. Massage for Low Back Pain (Cochrane Review). In: The Cochrane Library, Issue 4, 2001. Oxford: Update Software.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2014-10-27 03:49:21 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Furlan AD, Imamura M, Dryden T, Irvin E</AU>
<TI>Massage for low back pain</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>4</NO>
<PB>Cochrane Collaboration</PB>
<CY>UK</CY>
<IDENTIFIERS MODIFIED="2013-02-19 10:26:18 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-19 10:26:18 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001929.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Godlee-2000" MODIFIED="2013-02-19 10:26:47 -0500" MODIFIED_BY="[Empty name]" NAME="Godlee 2000" NOTES="&lt;p&gt;BJM: Clinical Evidence:  A Compendium of the Best Available Evidence for Effective Health Care.  London, England:  BMJ Publishing Group; [www.clinicalevidence.org, 2000 (Issue 4)]. &lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 10:26:47 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="BOOK">
<AU>Godlee Fiona (editor)</AU>
<SO>Clinical Evidence: A Compendium of the Best Available Evidence for Effective Health Care</SO>
<YR>2000</YR>
<VL>4</VL>
<EN>First</EN>
<PB>BMJ Publishing Group</PB>
<CY>London, England</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Green-1998" MODIFIED="2013-09-17 20:56:46 -0400" MODIFIED_BY="[Empty name]" NAME="Green 1998" TYPE="JOURNAL_ARTICLE">
<AU>Green S, Buchbinder R, Glazier R, Forbes A</AU>
<TI>Systematic review of randomised controlled trials of interventions for painful shoulder: selection criteria, outcomes assessment, and efficacy</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>316</VL>
<PG>354-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grewal-2009" MODIFIED="2014-10-28 13:05:15 -0400" MODIFIED_BY="[Empty name]" NAME="Grewal 2009" TYPE="JOURNAL_ARTICLE">
<AU>Grewal R, MacDermid JC, Shah P, King GJ</AU>
<TI>Functional outcome of arthroscopic extensor carpi radialis brevis tendon release in chronic lateral epicondylitis</TI>
<SO>Journal of Hand Surgery [American Volume]</SO>
<YR>2009</YR>
<VL>34</VL>
<NO>5</NO>
<PG>849-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Griffin-1963" MODIFIED="2014-10-27 03:50:12 -0400" MODIFIED_BY="[Empty name]" NAME="Griffin 1963" TYPE="JOURNAL_ARTICLE">
<AU>Griffin JE, Touchstone JC</AU>
<TI>Ultrasonic movement of cortisol into pig's tissue. I.Movement into skeletal muscle</TI>
<SO>American Journal of Physical Medicine</SO>
<YR>1963</YR>
<VL>42</VL>
<PG>77-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2008" MODIFIED="2014-10-27 03:50:48 -0400" MODIFIED_BY="[Empty name]" NAME="Guyatt 2008" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al</AU>
<TI>GRADE: an emerging consensus on rating quality of evidence and strength of recommendations</TI>
<SO>BMJ</SO>
<YR>2008</YR>
<VL>336</VL>
<PG>924-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Halle-1986" MODIFIED="2014-10-27 03:51:07 -0400" MODIFIED_BY="[Empty name]" NAME="Halle 1986" TYPE="JOURNAL_ARTICLE">
<AU>Halle JS, Franklin RJ, Karalfa L</AU>
<TI>Comparison of four treatment approaches for lateral epicondylitis of the elbow</TI>
<SO>Journal of Orthopedic Sports Physical Therapy</SO>
<YR>1986</YR>
<VL>8</VL>
<PG>62-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hart-1994" MODIFIED="2014-10-27 03:51:19 -0400" MODIFIED_BY="[Empty name]" NAME="Hart 1994" NOTES="&lt;p&gt;Hart LE. Exercises and soft tissue injury. Ballieres Clinical Rheumatology 8 (1): 137-148,1994.&lt;/p&gt;" NOTES_MODIFIED="2014-10-27 03:51:19 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Hart LE</AU>
<TI>Exercises and soft tissue injury</TI>
<SO>Ballieres Clinical Rheumatology</SO>
<YR>1994</YR>
<VL>8</VL>
<NO>1</NO>
<PG>137-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2014-10-27 03:52:01 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, Sterne JAC (editors)</AU>
<TI>Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions [Version 5.1.0] [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-2007" MODIFIED="2014-10-28 13:05:54 -0400" MODIFIED_BY="[Empty name]" NAME="Johnson 2007" TYPE="JOURNAL_ARTICLE">
<AU>Johnson GW, Cadwallader K, Scheffel SB, Epperly TD</AU>
<TI>Treatment of lateral epicondylitis</TI>
<SO>American Family Physician</SO>
<YR>2007</YR>
<VL>76</VL>
<NO>6</NO>
<PG>843-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jordaan-1994" NAME="Jordaan 1994" NOTES="&lt;p&gt;Jordaan G, Schwellnus MP.  The incidence of overuse injuries in military recruits during basic military training. Military Medicine 159 (6): 421-426, 1994.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Jordaan G, Schwellnus MP</AU>
<TI>The incidence of overuse injuries in military recruits during basic military training</TI>
<SO>Military Medicine</SO>
<YR>1994</YR>
<VL>159</VL>
<NO>6</NO>
<PG>1994</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kirk-2000" MODIFIED="2013-02-19 11:14:38 -0500" MODIFIED_BY="[Empty name]" NAME="Kirk 2000" NOTES="&lt;p&gt;Kirk KL, Kuklo T, Klemme W. Iliotibial band friction syndrome: a review. Orthopedics 23 (11): 1209-1217, 2000&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:14:38 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Kirk KL, Kuklo T, Klemme W</AU>
<TI>Iliotibial band friction syndrome: a review</TI>
<SO>Orthopedics</SO>
<YR>2000</YR>
<VL>23</VL>
<NO>11</NO>
<PG>1209-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lavine-2010" MODIFIED="2012-12-21 11:12:46 -0500" MODIFIED_BY="[Empty name]" NAME="Lavine 2010" TYPE="JOURNAL_ARTICLE">
<AU>Lavine R</AU>
<TI>Iliotibial band friction syndrome</TI>
<SO>Current Reviews in Musculoskeletal Medicine</SO>
<YR>2010</YR>
<VL>3</VL>
<PG>18-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Manal-1996" MODIFIED="2014-10-27 03:52:32 -0400" MODIFIED_BY="[Empty name]" NAME="Manal 1996" NOTES="&lt;p&gt;Manal RJ, Snyder-Mackler L.  Practice guidelines for anterior cruciate ligament rehabilitation:  criterion-based rehabilitation progression.  Operative Techniques in Orthopaedics.  1996;6:190-196.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2014-10-27 03:52:32 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Manal RJ, Snyder-Mackler L, Manal RJ, Snyder-Mackler L</AU>
<TI>Practice guidelines for anterior cruciate ligament rehabilitation: criterion-based rehabilitation progression</TI>
<SO>Operative Techniques in Orthopaedics</SO>
<YR>1996</YR>
<VL>6</VL>
<PG>190-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Martens-1989" MODIFIED="2013-02-19 11:15:33 -0500" MODIFIED_BY="[Empty name]" NAME="Martens 1989" NOTES="&lt;p&gt;Martens M, Libbrecht P, Burssens A. Surgical treatment of the iliotibial band friction syndrome. American Journal of Sports Medicine 17 (5): 651-654, 1989.&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:15:33 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Martens M, Libbrecht P, Burssens A</AU>
<TI>Surgical treatment of the iliotibial band friction syndrome</TI>
<SO>American Journal of Sports Medicine</SO>
<YR>1989</YR>
<VL>17</VL>
<NO>5</NO>
<PG>651-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Messier-1988" MODIFIED="2013-02-19 11:15:45 -0500" MODIFIED_BY="[Empty name]" NAME="Messier 1988" NOTES="&lt;p&gt;Messier SP, Pittala KA. Etiologic factors associated with selected running injuries. Medicine &amp;amp; Science in Sports and Exercise 20 (5): 501-505, 1988.&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:15:45 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Messier SP, Pittala KA</AU>
<TI>Etiologic factors associated with selected running injuries</TI>
<SO>Medicine &amp; Science in Sports and Exercise</SO>
<YR>1988</YR>
<VL>20</VL>
<NO>5</NO>
<PG>501-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Messier-1995" MODIFIED="2014-10-27 03:53:02 -0400" MODIFIED_BY="[Empty name]" NAME="Messier 1995" NOTES="&lt;p&gt;Messier SP, Edwards DG, Martin DF, Lowery RB, Cannon DW, James MK, Curl WW, Read HM, Hunter DM. Etiology of iliotibial friction syndrome in distance runners. Medicine and  Sciences in  Sports and exercises 27 (7): 951-960, 1995.&lt;/p&gt;" NOTES_MODIFIED="2014-10-27 03:53:02 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Messier SP, Edwards DG, Martin DF, Lowery RB, Cannon DW, James MK, et al</AU>
<TI>Etiology of iliotibial friction syndrome in distance runners</TI>
<SO>Medicine and Sciences in Sports and Exercises</SO>
<YR>1995</YR>
<VL>27</VL>
<NO>7</NO>
<PG>951-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morin-1996" MODIFIED="2013-04-23 10:19:29 -0400" MODIFIED_BY="[Empty name]" NAME="Morin 1996" NOTES="&lt;p&gt;Morin M., Brosseau L., Quirion-DeGrardi C.  A theoretical framework on low level laser therapy (classes I, II and III) application for the treatment of OA and RA. Procedings of the Canadian Physiotherapy Association. 1996.&lt;/p&gt;" NOTES_MODIFIED="2013-04-23 10:19:29 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="CONFERENCE_PROC">
<AU>Morin M, Brosseau L, Quirion-DeGrardi C</AU>
<TI>A theoretical framework on low level laser therapy (classes I, II and III) application for the treatment of OA and RA</TI>
<SO>Proceedings of the Canadian Physiotherapy Association</SO>
<YR>1996</YR>
<PG>1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Philadelphia-2001" NAME="Philadelphia 2001" NOTES="&lt;p&gt;The Philadelphia Panel: The Philadelphia Panel Evidence-Based Clinical Practice Guidelines on Selected Rehabilitation Interventions for Knee Pain. Physical Therapy 81 (10): 1-300, 2001&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>The Philadelphia Panel</AU>
<TI>The Philadelphia Panel Evidence-Based Clinical Practice Guidelines on Selected Rehabilitation Interventions for Knee Pain</TI>
<SO>Physical Therapy</SO>
<YR>2001</YR>
<VL>81</VL>
<NO>10</NO>
<PG>1-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pinshaw-1984" MODIFIED="2013-02-19 11:16:48 -0500" MODIFIED_BY="[Empty name]" NAME="Pinshaw 1984" NOTES="&lt;p&gt;Pinshaw R, Atlas V, Noakes TD. The nature and response to therapy of 196 consecutive injuries seen at a runners clinic. South African Medical Journal 65 (8): 291-298, 1984.&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:16:48 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Pinshaw R, Atlas V, Noakes TD</AU>
<TI>The nature and response to therapy of 196 consecutive injuries seen at a runners clinic</TI>
<SO>South African Medical Journal</SO>
<YR>1984</YR>
<VL>65</VL>
<NO>8</NO>
<PG>291-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reinold-2002" MODIFIED="2014-10-28 13:06:34 -0400" MODIFIED_BY="[Empty name]" NAME="Reinold 2002" TYPE="JOURNAL_ARTICLE">
<AU>Reinold MM, Wilk KE, Reed J, Crenshaw K, Andrews JR</AU>
<TI>Interval sport programs: guidelines for baseball, tennis, and golf</TI>
<SO>Journal of Orthopaedic and Sports Physical Therapy</SO>
<YR>2002</YR>
<VL>32</VL>
<NO>6</NO>
<PG>293-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Roquelaure-2006" MODIFIED="2013-02-19 11:18:44 -0500" MODIFIED_BY="[Empty name]" NAME="Roquelaure 2006" TYPE="JOURNAL_ARTICLE">
<AU>Roquelaure Y, Ha C, Leclerc A, Touranchet A, Sauteron M, Melchior M, et al</AU>
<TI>Epidemiologic surveillance of upper-extremity musculoskeletal disorders in the working population</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>5</NO>
<PG>765-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schwellnus-1991" MODIFIED="2013-02-19 11:19:12 -0500" MODIFIED_BY="[Empty name]" NAME="Schwellnus 1991" NOTES="&lt;p&gt;Schwellnus MP, Theunissen L, Noakes TD, Reinach SG. Anti-inflammatory and combined anti-inflammatory/analgesic medication in the early management of iliotibial band friction syndrome: a clinical trial. South Africa Medical Journal 79 (10): 602-606, 1991.&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:19:12 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Schwellnus MP, Theunissen L, Noakes TD, Reinach SG</AU>
<TI>Anti-inflammatory and combined anti-inflammatory/analgesic medication in the early management of iliotibial band friction syndrome: a clinical trial</TI>
<SO>South Africa Medical Journal</SO>
<YR>1991</YR>
<VL>79</VL>
<NO>10</NO>
<PG>602-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2011a" MODIFIED="2014-10-27 03:55:22 -0400" MODIFIED_BY="[Empty name]" NAME="Schünemann 2011a" TYPE="OTHER">
<AU>Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH</AU>
<TI>Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions [Version 5.1.0] [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2011b" MODIFIED="2014-10-27 03:56:00 -0400" MODIFIED_BY="[Empty name]" NAME="Schünemann 2011b" TYPE="OTHER">
<AU>Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH</AU>
<TI>Chapter 11: Presenting results and &#8216;Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions [Version 5.1.0] [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shiri-2006" MODIFIED="2012-12-21 11:13:04 -0500" MODIFIED_BY="[Empty name]" NAME="Shiri 2006" TYPE="JOURNAL_ARTICLE">
<AU>Shiri R, Viikari-Juntura E, Varonen H, Helio M</AU>
<TI>Prevalence and determinants of lateral and medial epicondylitis: a population study</TI>
<SO>American Journal of Epidemiology</SO>
<YR>2006</YR>
<VL>164</VL>
<NO>11</NO>
<PG>1065&#8211;74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strauss-2011" MODIFIED="2014-10-28 13:07:03 -0400" MODIFIED_BY="[Empty name]" NAME="Strauss 2011" TYPE="JOURNAL_ARTICLE">
<AU>Strauss EJ, Kim S, Calcei JG, Park D</AU>
<TI>Iliotibial band syndrome: evaluation and management</TI>
<SO>Journal of the American Academy of Orthopaedic Surgeons</SO>
<YR>2011</YR>
<VL>19</VL>
<NO>12</NO>
<PG>728-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Struijs-2002" MODIFIED="2013-02-19 11:22:28 -0500" MODIFIED_BY="[Empty name]" NAME="Struijs 2002" NOTES="&lt;p&gt;Struijs PAAA , Smidt N, Arola H, Dijk van CN, Buchbinder R, Assendelt WJJ. Orthotics devices for tennis elbow (Cochrane Review). In The Cochrane Library, Issue 2 2002 . Ox ford: Update Software.&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:22:28 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Struijs PAA, Smidt N, Arola H, van Dijk CN, Buchbinder R, Assendelt WJJ</AU>
<TI>Orthotics devices for the treatment of tennis elbow</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-02-19 11:21:04 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-19 11:21:04 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001821"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Thaunton-1987" MODIFIED="2013-04-16 10:28:14 -0400" MODIFIED_BY="[Empty name]" NAME="Thaunton 1987" NOTES="&lt;p&gt;Thaunton JE, Clement DB, Smart GW, McNicol KL. Non-surgical management of overuse knee injuries in runners. Canadian Journal of Sprot Sciences 12 (1): 11-18, 1987.&lt;/p&gt;" NOTES_MODIFIED="2013-04-16 10:28:14 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Thaunton JE, Clement DB, Smart GW, McNicol KL</AU>
<TI>Non-surgical management of overuse knee injuries in runners</TI>
<SO>Canadian Journal of Sport Sciences</SO>
<YR>1987</YR>
<VL>12</VL>
<NO>1</NO>
<PG>1987</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-van-der-Heijden-1997" MODIFIED="2013-02-19 11:23:07 -0500" MODIFIED_BY="[Empty name]" NAME="van der Heijden 1997" NOTES="&lt;p&gt;van der Heijden GJ, van der Windt DA, de Winter AF.  Physiotherapy for patients with soft tissue shoulder disorders:  a systematic review of randomised clinical trials.  BMJ  1997;315(7099):25-30.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-02-19 11:23:07 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>van der Heijden GJ, van der Windt DA, de Winter AF, van der Heijden GJ, van der Windt DA, de Winter AF</AU>
<TI>Physiotherapy for patients with soft tissue shoulder disorders: a systematic review of randomised clinical trials</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7099</NO>
<PG>25-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walker-1984" MODIFIED="2013-02-19 11:23:46 -0500" MODIFIED_BY="[Empty name]" NAME="Walker 1984" TYPE="JOURNAL_ARTICLE">
<AU>Walker JM</AU>
<TI>Deep transverse frictions in ligament healing</TI>
<SO>Journal of Orthopaedic and Sports Physical Therapy</SO>
<YR>1984</YR>
<VL>6</VL>
<NO>2</NO>
<PG>89-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walker_x002d_Bone-2004" MODIFIED="2013-02-19 11:24:31 -0500" MODIFIED_BY="[Empty name]" NAME="Walker-Bone 2004" TYPE="JOURNAL_ARTICLE">
<AU>Walker-Bone K, Palmer KT, Reading I, Coggon D, Cooper C</AU>
<TI>Prevalence and impact of musculoskeletal disorders of the upper limb in the general population</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>2004</YR>
<VL>51</VL>
<NO>4</NO>
<PG>642-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wilk-2004" MODIFIED="2014-10-28 13:07:21 -0400" MODIFIED_BY="[Empty name]" NAME="Wilk 2004" TYPE="JOURNAL_ARTICLE">
<AU>Wilk KE, Reinold MM, Andrews JR</AU>
<TI>Rehabilitation of the thrower's elbow</TI>
<SO>Clinics in Sports Medicine</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>4</NO>
<PG>765-801, xii</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-10-27 11:05:45 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-10-27 11:05:45 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-10-27 04:48:02 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schwellnus-1992">
<CHAR_METHODS MODIFIED="2014-10-27 04:47:31 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: randomized, assessor-blinded trial<BR/>
</P>
<P>Sample size at entry: 20<BR/>G1: deep transverse friction massage (DTFM) group 10<BR/>G2: control group 10<BR/>Treatment duration: 10 days<BR/>Follow-up: 14 days<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-27 04:48:02 -0400" MODIFIED_BY="[Empty name]">
<P>Setting: visitors to a sports injury clinic with unilateral chronic (&gt; 4 weeks) iliotibial band syndrome causing pain severe enough to restrict running distance or speed (grade 3), or to prevent it altogether (grade 4)<BR/>
</P>
<P>Inclusion criteria:</P>
<UL>
<LI>Age in years (mean (± SE)): DTFM group 25 (± 6), control group 29 (± 5), P value 0.20 student t-test</LI>
<LI>Weeks injured (mean (± SE)): DTFM group 23 (± 17), control group 74 (± 95)</LI>
<LI>Years of running (mean (± SE)): DTFM group 7.7 (± 5.5), control group 5.4 (± 6.2)</LI>
<LI>Kilometers run per week (mean (± SE)): DTFM group 45 (± 15), control group 64 (± 30)</LI>
<LI>Grade of injury (mean (± SE)): DTFM group 3.4 (± 0.5), control group 3.4 (± 0.5)</LI>
</UL>
<P>Exclusion criteria: &lt; 18 years old, history of previous knee surgery, concomitant medical therapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-27 04:43:36 -0400" MODIFIED_BY="[Empty name]">
<P>Deep transverse friction massage: applied on days 3, 5, 7 and 10</P>
<P>Treated anatomical area (most tender area) with constant pressure, such that discomfort was experienced, but not severe pain; 2 minutes of light friction, then 8 minutes of harder friction</P>
<P>Technique: Pressure was applied with the index finger and reinforced with the ring finger, with the thumb acting as a pivot; brisk motion was initiated from the therapist's shoulder, with the wrist flexible and the hand stiff</P>
<P>Concurrent treatment:</P>
<UL>
<LI>Rest (apart from 3 * 30 min treadmill exercise tests on days 3, 7 and 14)</LI>
<LI>Ice 20 minutes twice daily</LI>
<LI>Stretch of iliotibial band, daily</LI>
<LI>Ultrasound: 1 MHz, 0.5 W/cm/cm (continuous), 5 minutes on days 3, 4, 5 and 6, then 7 minutes on days 7 and 10</LI>
<LI>G1 received deep transverse friction massage and concurrent treatment while control group received concurrent treatment only</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-27 04:07:00 -0400" MODIFIED_BY="[Empty name]">
<P>Mean pain daily recall, total pain while running, % max pain experienced while running (VAS 0 to 10; 0 = no pain) for 3 treatment periods (days 0 to 2, 3 to 6, 7 to 14)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-27 04:43:46 -0400" MODIFIED_BY="[Empty name]">
<P>One participant was excluded for refusal to comply with the treatment group. Two participants were not accounted for in the control group (reasons not provided)</P>
<P>Per-protocol analysis</P>
<P>Source of funding: "This research project was generously supported financially by Johnson and Johnson Pty Ltd"</P>
<P>Declarations of interest of primary researchers not provided</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-27 04:44:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stratford-1989">
<CHAR_METHODS MODIFIED="2014-10-27 02:58:57 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: randomized controlled trial, parallel group, combination of interventions</P>
<P>Sample size at entry: 40<BR/>Group 1: ultrasound and placebo ointment without frictions&#8212;9<BR/>Group 2: ultrasound and placebo ointment with frictions&#8212;11<BR/>Group 3: phonophoresis without frictions&#8212;10<BR/>Group 4: phonophoresis with frictions&#8212;10<BR/># male/# female: 20/20<BR/>Group 1: 2/7<BR/>Group 2: 5/6<BR/>Group 3: 5/5<BR/>Group 4: 8/2</P>
<P>Treatment duration: 9 sessions within 5 weeks</P>
<P>Follow-up: 5 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-27 03:09:51 -0400" MODIFIED_BY="[Empty name]">
<P>Setting: patients attending a community sports injuries clinic</P>
<P>Inclusion criteria: those who complained of discomfort at or about the lateral epicondyle; pain at the lateral aspect of the elbow during resisted wrist extension; radial deviation during complete elbow extension; tenderness in palpation over, or at, one of the following areas: (1) origin of extensor carpi radialis longus tendon, (2) origin of extensor carpi radialis brevis tendon, (3) extensor carpi radialis brevis at tendon body, and (4) extensor carpi radialis brevis tendon with tenderness extending from origin to the tendon body</P>
<P>Age (mean in years (± SD))<BR/>Group 1: 43.8 (± 9.8)<BR/>Group 2: 44.6 (± 9.8)<BR/>Group 3: 40.1 (± 8.3)<BR/>Group 4: 44.7 (± 8.7)</P>
<P>Disease duration (months: mean (± SD))<BR/>Group 1: 4.3 (± 3.2)<BR/>Group 2: 2.1 (± 1.2)<BR/>Group 3: 5.2 (± 7.2)<BR/>Group 4: 5.4 (± 4.1)</P>
<P>Exclusion criteria: combined lesions; bilateral elbow problems at initial assessment; history of prior surgery; history of an injection to the elbow within the past 6 months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-27 04:44:19 -0400" MODIFIED_BY="[Empty name]">
<P>Deep transverse friction massage<BR/>Treated anatomical area (elbow) with friction massage applied perpendicular to the structure of interest for 10 minutes, 3 times per week, 9 treatment sessions within 5 weeks<BR/>Frictions for groups 2 and 4: position of participant: for lesion at origin of the extensor carpi radialis longus or brevis tendon, elbow flexed at 90 degrees with forearm fully supinated; if lesion at or included tendon body or extensor carpi radialis brevis tendon, elbow flexed at 45 degrees with forearm pronated</P>
<P>Concurrent treatment for group 1 and group 2: ultrasound and placebo ointment<BR/>Ultrasound: Dosage varied from 1.3 w/cm<SUP>2</SUP> continuous output to 0.5 w/cm<SUP>2</SUP> pulsed (1:4). Application technique: sound head moved in slow concentric circles, while sound head contact with the participant was maintained at the same time. Duration: 6 minutes<BR/>
</P>
<P>Concurrent treatment for groups 3 and 4: phonophoresis<BR/>Phonophoresis: 10% hydrocortisone ointment used with ultrasound treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-27 04:15:49 -0400" MODIFIED_BY="[Empty name]">
<P>Pain</P>
<UL>
<LI>Pain-free function (8 pain-free item, 8 = better)</LI>
<LI>Pain VAS (0 to 100 mm; 0 = worst).</LI>
</UL>
<P>Grip strength</P>
<UL>
<LI>Ration index of pain-free grip strength (grip strength: kilograms of force). Ratio is pain-free grip divided by maximum grip of uninvolved limb</LI>
</UL>
<P>Function</P>
<UL>
<LI>Function VAS (0 to 100 mm; 0 = worst)</LI>
</UL>
<P>Functional status (success or failure to perform pain-free strengthening program for the wrist extensor muscles, with the elbow extended, without subsequent regression within 2 weeks of follow-up)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-27 03:13:52 -0400" MODIFIED_BY="[Empty name]">
<P>We extracted the outcome of pain on VAS (0 to 100), not pain-free function, for the review</P>
<P>Source of funding: "This work was supported by the Physiotherapy Foundation of Canada"</P>
<P>Declarations of interest of primary researchers not provided</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>DTFM: Deep transverse friction massage.</P>
<P>SD: Standard deviation.</P>
<P>SE: Standard error.</P>
<P>VAS: Visual analog scale.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-10-27 04:08:57 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2014-10-27 03:16:04 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Balke-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 03:16:04 -0400" MODIFIED_BY="[Empty name]">
<P>Not tendinitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 03:18:39 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Baltaci-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 03:18:39 -0400" MODIFIED_BY="[Empty name]">
<P>Combination of interventions; co-interventions not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 03:18:44 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bisset-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 03:18:44 -0400" MODIFIED_BY="[Empty name]">
<P>Combination of Interventions; co-interventions not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 03:16:17 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chiarello-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 03:16:17 -0400" MODIFIED_BY="[Empty name]">
<P>Healthy participants</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 03:16:24 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Crosman-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 03:16:24 -0400" MODIFIED_BY="[Empty name]">
<P>Healthy participants</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 03:16:27 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Feehan-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 03:16:27 -0400" MODIFIED_BY="[Empty name]">
<P>Not tendinitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-03 16:36:26 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fernandez-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-03 16:36:26 -0500" MODIFIED_BY="[Empty name]">
<P>Combination of Interventions; co-interventions not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-03 16:36:27 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fernandez-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-03 16:36:27 -0500" MODIFIED_BY="[Empty name]">
<P>Combination of Interventions; co-interventions not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 04:08:24 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Iwatsuki-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 04:08:24 -0400" MODIFIED_BY="[Empty name]">
<P>Study was not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 04:08:31 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Joseph-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 04:08:31 -0400" MODIFIED_BY="[Empty name]">
<P>Study was not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-08 15:23:09 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kohia-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-08 15:23:09 -0400" MODIFIED_BY="[Empty name]">
<P>No control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-02-27 10:49:27 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Malier-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-02-27 10:49:27 -0500" MODIFIED_BY="[Empty name]">
<P>No control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-09 09:23:43 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mayer-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-09 09:23:43 -0400" MODIFIED_BY="[Empty name]">
<P>No control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-09 13:16:41 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nagrale-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-09 13:16:41 -0500" MODIFIED_BY="[Empty name]">
<P>Combination of Interventions; co-interventions not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-09 13:15:20 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pellecchia-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-09 13:15:20 -0500" MODIFIED_BY="[Empty name]">
<P>Combination of Interventions; co-interventions not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-03 16:36:29 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smidt-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-03 16:36:29 -0500" MODIFIED_BY="[Empty name]">
<P>Combination of Interventions; co-interventions not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-03 16:36:29 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stasinopoulos-2004a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-03 16:36:29 -0500" MODIFIED_BY="[Empty name]">
<P>Combination of Interventions; co-interventions not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-09 09:25:04 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stasinopoulos-2004b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-09 09:25:04 -0400" MODIFIED_BY="[Empty name]">
<P>No control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-03 16:36:30 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stasinopoulos-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-03 16:36:30 -0500" MODIFIED_BY="[Empty name]">
<P>Combination of interventions: Cyriax and Mill's manipulation; co-intervention not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-08 15:23:30 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Struijs-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-08 15:23:30 -0400" MODIFIED_BY="[Empty name]">
<P>Pilot study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-03 16:36:30 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Struijs-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-03 16:36:30 -0500" MODIFIED_BY="[Empty name]">
<P>Combination of Interventions; co-interventions not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 03:17:24 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Thomee-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 03:17:24 -0400" MODIFIED_BY="[Empty name]">
<P>Not tendinitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-09 09:27:51 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Verhaar-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-09 09:27:51 -0400" MODIFIED_BY="[Empty name]">
<P>No control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-03 16:36:31 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Viswas-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-03 16:36:31 -0500" MODIFIED_BY="[Empty name]">
<P>Combination of interventions: Cyriax and Mill's manipulation; co-intervention not applied to the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 03:17:40 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 03:17:40 -0400" MODIFIED_BY="[Empty name]">
<P>Not tendinitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 04:08:57 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zheng-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 04:08:57 -0400" MODIFIED_BY="[Empty name]">
<P>Study was not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-10-27 04:43:51 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-10-27 03:14:01 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 02:53:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwellnus-1992">
<DESCRIPTION>
<P>Quote: ''patients were divided into two treatment groups on a random basis''</P>
<P>Comments: method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 03:14:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stratford-1989">
<DESCRIPTION>
<P>Quote: ''The study design was a two by two factorial design. The subjects were randomly assigned using a balanced blocked randomization table''</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-10-27 03:14:08 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 02:53:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwellnus-1992">
<DESCRIPTION>
<P>Comments: Investigators state that they divided the 17 athletes into 2 groups without explaining the method of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 03:14:08 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stratford-1989">
<DESCRIPTION>
<P>Comments: Method of allocation concealment was not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-11-27 16:46:26 -0500" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-10-27 03:14:18 -0400" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.02" NO="2">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-10-27 02:53:55 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwellnus-1992">
<DESCRIPTION>
<P>Comment: Participants and personnel were not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-10-27 03:14:18 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stratford-1989">
<DESCRIPTION>
<P>Comment: Participants and personnel were not blinded to treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2014-10-27 03:15:00 -0400" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.02" NO="2">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-10-27 02:54:29 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwellnus-1992">
<DESCRIPTION>
<P>Quote: ''the efficacy of the treatment was assessed by a different therapist who was blind to the treatment group of the patient''</P>
<P>Comments: Insufficient information available to judge whether not blinding the participants had an impact on patient-reported outcomes. More likely at 'high risk' for self-reported subjective outcomes (eg, pain)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-10-27 03:15:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stratford-1989">
<DESCRIPTION>
<P>Quote: ''Decision was made by the assessor who was blind to both interventions''</P>
<P>Comments: Insufficient information was available on which to base judgement if not blinding participants had an impact on patient-reported outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-10-27 04:43:51 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-27 04:43:51 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwellnus-1992">
<DESCRIPTION>
<P>Comments: This study had a 15% dropout rate (even across treatment groups). Duration of follow-up was mentioned, but investigators did not perform an intention-to-treat analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-27 03:15:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stratford-1989">
<DESCRIPTION>
<P>Comments: No description of withdrawals and dropouts was mentioned. However, all randomly assigned participants were accounted for in the results</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-10-27 03:15:33 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 02:55:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwellnus-1992">
<DESCRIPTION>
<P> Comments: The trial presented planned outcomes whether or not the result was significant. No selective reporting was found to be present</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 03:15:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stratford-1989">
<DESCRIPTION>
<P>Comments: The trial presented all planned outcomes whether or not the result was significant. No selective reporting was found to be present</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2014-10-27 03:15:55 -0400" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 02:55:34 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwellnus-1992">
<DESCRIPTION>
<P>Comment: Baseline imbalance was reported; mean age and duration of symptoms were different across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 03:15:55 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stratford-1989">
<DESCRIPTION>
<P>Comments: Baseline imbalance was reported; the duration of symptoms was different across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2014-10-27 04:50:27 -0400" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2014-10-27 04:49:41 -0400" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2014-10-27 03:19:13 -0400" MODIFIED_BY="[Empty name]">Massage + ultrasound and placebo ointment compared with ultrasound + placebo ointment only for treating lateral elbow tendinitis (tennis elbow)</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Massage + therapeutic ultrasound and placebo ointment compared with ultrasound + placebo ointment only (follow-up 2 weeks) for treating tendinitis</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with extensor carpi radialis tendinitis<BR/>
<B>Settings: </B>community sports injuries clinic in Canada<BR/>
<B>Intervention:</B> massage + therapeutic ultrasound and placebo ointment<BR/>
<B>Comparison: </B>therapeutic ultrasound + placebo ointment only</P>
<P/>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control (US + placebo ointment only) </B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Massage + US and placebo ointment</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Pain </B>
<BR/>Visual analog scale</P>
<P>Scale from 0 to 100 (lower is better)<BR/>Follow-up: mean 2 weeks</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean change in pain in the control groups was<BR/>
<B>4.6 mm</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean change in pain in the intervention groups was<BR/>
<B>6.6 lower</B>
<BR/>(15.40 lower to 28.60 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>Very low</B>
<SUP>a,b,c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>MD = -6.60 (-28.60 to 15.40)</P>
<P/>
<P>Absolute improvement = -7% (-29% to -15%)</P>
<P/>
<P>Relative percentage change = 8% (-24% to 37%)</P>
<P/>
<P>Not statistically significant</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Proportion reporting pain relief of 30% or greater</B> not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Function </B>
<BR/>Visual analog function index </P>
<P>Scale from 0 to 100 (higher is better)<BR/>Follow-up: mean 2 weeks</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean function (vas 0 to 100, 0 = worst) in the control groups was<BR/>
<B>78.1 mm</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean function (VAS 0-100, 0 = worst) in the intervention groups was<BR/>
<B>1.8 lower</B>
<BR/>(18.64 lower to 15.04 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>Very low</B>
<SUP>a,b,c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>MD = -1.80 (-18.64 to 15.04)</P>
<P/>
<P>Absolute improvement = 2% (-19% to 15%)</P>
<P/>
<P>Relative percentage change = -3% (-28% to 23%)</P>
<P/>
<P>Not statistically significant</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Quality of life</B>&#8212;not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Patient global assessment of success</B> not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Adverse events </B>not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Withdrawals due to adverse events </B>not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>ECRT:</B> Extensor carpi radialis tendinitis; <B>RR:</B> Risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Allocation concealment was unclear. Only assessors were blinded. Baseline imbalance was reported.<BR/>
<SUP>b</SUP>Very few participants.<BR/>
<SUP>c</SUP>Wide confidence intervals.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2014-10-27 04:50:02 -0400" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2014-10-27 03:25:29 -0400" MODIFIED_BY="[Empty name]">Massage + phonophoresis compared with phonophoresis alone for treating lateral elbow tendinitis (tennis elbow)</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Massage + phonophoresis compared with control (phonophoresis only) (follow-up 2 weeks) for treating tendinitis</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with extensor carpi radialis tendinitis<BR/>
<B>Settings: </B>community sports injuries clinic in Canada<BR/>
<B>Intervention:</B> massage + phonophoresis<BR/>
<B>Comparison: </B>phonophoresis only</P>
<P/>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control (phonophoresis only) (follow-up 2 weeks)</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Massage + phonophoresis</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Pain </B>
<BR/>Visual analog scale</P>
<P>Scale from 0 to 100 (lower is better)<BR/>Follow-up: mean 2 weeks</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean change in pain in the control groups was<BR/>
<B>1 mm</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean change in pain in the intervention groups was<BR/>
<B>1.2 lower</B>
<BR/>(17.84 lower to 20.24 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>Very low</B>
<SUP>a,b,c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>MD = -1.2 (-20.24 to 17.84)</P>
<P/>
<P>Absolute improvement = -1%<BR/>(-20% to 18%)</P>
<P/>
<P>Relative percentage change = 6% (-86% to 97%)</P>
<P/>
<P>Not statistically significant</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Proportion reporting pain relief of 30% or greater</B> not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Function </B>
<BR/>Visual analog scale</P>
<P>Scale from 0 to 100 (higher is better)<BR/>Follow-up: mean 2 weeks</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean function in the control groups was<BR/>
<B>78.8 mm</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean function in the intervention groups was<BR/>
<B>3.7 higher</B>
<BR/>(14.13 lower to 21.53 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>Very low</B>
<SUP>a,b,c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>MD = 3.70 (-14.13 to 21.53)</P>
<P/>
<P>Absolute improvement = 4% (-14% to 22%)</P>
<P/>
<P>Relative percentage change = 5% (-18% to 28%)</P>
<P/>
<P>Not statistically significant</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Quality of life </B>not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Patient global assessment of success</B> not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Adverse events</B> not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Withdrawals due to adverse events </B>not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>ECRT:</B> extensor carpi radialis tendinitis; <B>RR:</B> Risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Allocation concealment was unclear. Only assessors were blinded. Baseline imbalance was reported.<BR/>
<SUP>b</SUP>Very few participants.<BR/>
<SUP>c</SUP>Wide confidence interval.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2014-10-27 04:50:27 -0400" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2014-10-27 03:30:33 -0400" MODIFIED_BY="[Empty name]">Deep transverse massage + physical therapy compared with physical therapy alone for treating lateral knee tendinitis</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Deep transverse friction massage + physical therapy compared with physical therapy alone </B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>patients with iliotibial band friction syndrome (knee tendinitis)</P>
<P>
<B>Settings: </B>community sports injury clinic in South Africa</P>
<P>
<B>Intervention: </B>deep transverse massage and physical therapy</P>
<P>
<B>Comparison: </B>physical therapy alone</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Control</P>
</TH>
<TH VALIGN="TOP">
<P>Deep transverse massage</P>
</TH>
</TR>
<TR>
<TD>
<P>
<B>Daily pain</B>
<BR/>Visual<BR/>analog scale (VAS)<BR/>Scale from 0 to<BR/>10 (lower is better)</P>
<P>Follow-up mean 2<BR/>weeks</P>
</TD>
<TD>
<P>Mean daily pain<BR/>in the control groups was<BR/>
<B>1 point</B>
</P>
</TD>
<TD>
<P>Mean daily pain in</P>
<P>the intervention groups was<BR/>
<B>0.4 lower</B>
<BR/>(0.8 lower to 0.00 higher)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>17<BR/>(1 study)</P>
</TD>
<TD>
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>a,b</SUP>
</P>
</TD>
<TD>
<P>MD = -0.4 (-0.8 to 0)</P>
<P/>
<P>Absolute improvement = -4% (-8% to 0%)</P>
<P/>
<P>Relative percentage change = -40% (-80% to 0%)</P>
<P/>
<P>Not statistically significant</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Proportion reporting pain relief of 30% or greater</B> not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Function </B>not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Quality of life </B>not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Patient global assessment </B>not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Adverse events </B>not measured</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Withdrawals due to adverse events </B>
</P>
</TD>
<TD>
<P/>
<P/>
<P>See comment</P>
</TD>
<TD>
<P/>
<P/>
<P>See comment</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>
<BR/>
</P>
<P>-</P>
</TD>
<TD>
<P>
<BR/>
</P>
<P>See comment</P>
</TD>
<TD>
<P/>
<P>Not measured</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>ITBF:</B> Iliotibial band friction syndrome (knee tendinitis); <B>RR:</B> Risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Randomization and allocation concealment were unclear. Only assessors were blinded. No intention-to-treat analysis was done, and baseline imbalance was reported.<BR/>
<SUP>b</SUP>Very few participants.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2014-10-28 13:04:26 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2014-10-28 13:04:26 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-10-27 03:33:42 -0400" MODIFIED_BY="[Empty name]">Inclusion and exclusion critieria according to the PICOTS strategy</TITLE>
<TABLE COLS="2" ROWS="7">
<TR>
<TD VALIGN="TOP">
<P>
<B>Inclusion</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Exclusion</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Participants/Population (P)</B>
</P>
<UL>
<LI>Outpatients or inpatients</LI>
<LI>Diagnosis: tendinitis pain</LI>
<LI>Chronic versus acute conditions</LI>
<LI>Normal weight (BMI &lt; 25 kg/m<SUP>2</SUP>)</LI>
<LI>Age groups &#8805; 18 years</LI>
<LI>Medically stable</LI>
<LI>Mentally competent</LI>
</UL>
<P/>
</TD>
<TD VALIGN="TOP">
<P>
<B>Participants/Population (P)</B>
</P>
<UL>
<LI>Cancer (and other oncologic conditions)</LI>
<LI>Dermatologic conditions</LI>
<LI>Healthy normal</LI>
<LI>Mixed population</LI>
<LI>Multiple conditions (presenting other chronic problems additional)</LI>
<LI>Neurologic conditions</LI>
<LI>Pediatric conditions</LI>
<LI>Psychiatric conditions</LI>
<LI>Pulmonary conditions</LI>
<LI>Scoliosis</LI>
<LI>Condition in which rapid weight loss or exercise is contraindicated (angina, frailty, advanced osteoporosis)</LI>
<LI>Obese or overweight patient (BMI &#8805; 25 kg/m<SUP>2</SUP>)</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Interventions (I)</B>
</P>
<UL>
<LI>Eligible interventions: deep transverse frictions  techniques only, in community or not, and with or without:</LI>
</UL>
<UL>
<UL>
<LI>Concurrent programs (eg, stretching exercises, modalities (ultrasound), phonophoresis)</LI>
<LI>Supervision</LI>
</UL>
</UL>
<UL>
<LI>Eligible control groups: conventional therapy, untreated, waiting list, active physical therapy treatments, educational pamphlets</LI>
</UL>
</TD>
<TD VALIGN="TOP">
<P>
<B>Interventions (I)</B>
</P>
<UL>
<LI>Surgery (ie, not the effects of surgery)</LI>
<LI>Medication (eg, phonophoresis with medications)</LI>
<LI>Thermal biofeedback</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Comparisons (C)</B>
</P>
<P>Studies were included if they compared an intervention group (eg, deep transverse frictions techniques combined with modalities, exercises) with a comparison group (eg, placebo, no treatment, active treatment such as modalities, exercises)</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Comparisons (C)</B>
</P>
<P>Studies were excluded if they did not compare the intervention group with a comparison group (eg, placebo, no treatment, active treatment such as modalities, exercises)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Outcomes (O)</B>
</P>
<UL>
<LI>Functional status (self-care activities)</LI>
<LI>Medication intake (if reported)</LI>
<LI>Muscle strength</LI>
<LI>Pain intensity</LI>
<LI>Participant satisfaction</LI>
<LI>Quality of life</LI>
<LI>Compliance</LI>
</UL>
<P/>
</TD>
<TD VALIGN="TOP">
<P>
<B>Outcomes (O)</B>
</P>
<UL>
<LI>Biochemical measures</LI>
<LI>Participant compliance with medication</LI>
<LI>Psychosocial measures (depression, home and community activities, leisure, social roles, sexual functions)</LI>
<LI>Serum markers (except ESR)</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Period of time (P)</B>
</P>
<P>Studies were included if the intervention period lasted longer than 1 week or 1 treatment session, with or without a follow-up period </P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Period of time (P)</B>
</P>
<P>Studies were excluded if the intervention period lasted less than 1 week or 1 treatment session </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Study designs (S)</B>
</P>
<UL>
<LI>Randomized controlled trial</LI>
<LI>Controlled clinical trial</LI>
</UL>
<P>*English and French articles only.</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Study designs (S)</B>
</P>
<UL>
<LI>Case series/case report</LI>
</UL>
<UL>
<LI>Case control studies</LI>
<LI>Cohort studies</LI>
<LI>Data (graphic) without a mean and SD</LI>
<LI>Sample size of fewer than 5 participants per experimental group</LI>
<LI>Studies with greater than 20% dropout rate</LI>
</UL>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>BMI: Body mass index.<BR/>ESR: Erythrocyte sedimentation rate.<BR/>PICOTS: Populations, interventions, comparators, outcomes, timing, and setting framework.<BR/>SD: Standard deviation.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-10-27 03:57:38 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2014-09-24 13:17:52 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Massage + therapeutic ultrasound (US) and placebo ointment vs US + placebo ointment only</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2014-09-24 13:17:52 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="9" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain (VAS 0-100, 0 = worst) (change from baseline)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="15.40349518066468" CI_START="-28.60349518066468" EFFECT_SIZE="-6.6" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-4.6" MODIFIED="2014-09-24 13:17:11 -0400" MODIFIED_BY="[Empty name]" ORDER="16743" SD_1="30.2" SD_2="19.7" SE="11.226479340551888" STUDY_ID="STD-Stratford-1989" TOTAL_1="11" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2013-12-02 10:49:56 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="9" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Grip strength (ratio index, higher is better)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3642814897619625" CI_START="-0.16428148976196255" EFFECT_SIZE="0.09999999999999998" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="0.6" ORDER="16744" SD_1="0.3" SD_2="0.3" SE="0.13483997249264842" STUDY_ID="STD-Stratford-1989" TOTAL_1="11" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2013-12-02 10:50:12 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="9" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function (VAS 0-100, 0 = worst)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="15.043254618497958" CI_START="-18.643254618497952" EFFECT_SIZE="-1.7999999999999972" ESTIMABLE="YES" MEAN_1="76.3" MEAN_2="78.1" ORDER="16745" SD_1="21.9" SD_2="16.5" SE="8.593655164765984" STUDY_ID="STD-Stratford-1989" TOTAL_1="11" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2013-12-02 10:50:40 -0500" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="9" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function (pain-free function; average number of pain-free items; higher is better)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.2043180248415077" CI_START="-1.0043180248415084" EFFECT_SIZE="1.0999999999999996" ESTIMABLE="YES" MEAN_1="3.8" MEAN_2="2.7" ORDER="16746" SD_1="2.7" SD_2="2.1" SE="1.0736513739232456" STUDY_ID="STD-Stratford-1989" TOTAL_1="11" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2014-09-17 15:18:20 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Functional status (number of successes to perform strengthening program)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="24.33841901402626" CI_START="0.4400755774432298" EFFECT_SIZE="3.272727272727273" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.3862923637139084" LOG_CI_START="-0.3564727324957841" LOG_EFFECT_SIZE="0.5149098156090622" ORDER="16747" O_E="0.0" SE="1.0237088443399314" STUDY_ID="STD-Stratford-1989" TOTAL_1="11" TOTAL_2="9" VAR="1.047979797979798" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2014-09-24 13:18:46 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Massage + phonophoresis vs phonophoresis only</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2014-09-24 13:18:46 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain (VAS 0-100, 0 = worst)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="17.836739819518804" CI_START="-20.236739819518803" EFFECT_SIZE="-1.2" ESTIMABLE="YES" MEAN_1="-0.2" MEAN_2="1.0" MODIFIED="2014-09-22 15:35:19 -0400" MODIFIED_BY="[Empty name]" ORDER="16748" SD_1="18.85" SD_2="24.25" SE="9.7128008318919" STUDY_ID="STD-Stratford-1989" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2013-12-02 10:52:03 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Grip strength (ratio index, higher is better)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.06295676217297458" CI_START="-0.4629567621729745" EFFECT_SIZE="-0.19999999999999996" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.7" ORDER="16749" SD_1="0.3" SD_2="0.3" SE="0.1341640786499874" STUDY_ID="STD-Stratford-1989" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2013-12-02 10:52:14 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function (VAS 0-100, 0 = worst)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="21.5279168695221" CI_START="-14.127916869522096" EFFECT_SIZE="3.700000000000003" ESTIMABLE="YES" MEAN_1="82.5" MEAN_2="78.8" ORDER="16750" SD_1="16.3" SD_2="23.7" SE="9.096043095764223" STUDY_ID="STD-Stratford-1989" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2013-12-02 10:52:26 -0500" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function (pain-free function; average number of pain-free items; higher is better)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.4682334931787078" CI_START="-2.2682334931787076" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="3.7" MEAN_2="3.6" ORDER="16751" SD_1="2.8" SD_2="2.6" SE="1.2083045973594573" STUDY_ID="STD-Stratford-1989" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-12-02 10:52:35 -0500" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Functional status (number of successes to perform strengthening program)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.171860056625685" CI_START="0.1401210761225251" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5013140178713021" LOG_CI_START="-0.8534965359826647" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="16752" O_E="0.0" SE="0.7958224257542215" STUDY_ID="STD-Stratford-1989" TOTAL_1="10" TOTAL_2="10" VAR="0.6333333333333333" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2014-10-27 03:57:38 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Massage + physical therapy vs physical therapy only</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2014-10-27 03:57:38 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="27" TOTAL_2="24" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.01" MODIFIED="2012-05-15 15:28:13 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>Daily pain</NAME>
<CONT_DATA CI_END="-0.0019294329473319438" CI_START="-0.7980705670526681" EFFECT_SIZE="-0.4" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="1.0" MODIFIED="2012-05-15 15:28:13 -0400" MODIFIED_BY="[Empty name]" ORDER="11" SD_1="0.3" SD_2="0.5" SE="0.203100960115899" STUDY_ID="STD-Schwellnus-1992" TOTAL_1="9" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.02" MODIFIED="2012-05-15 15:20:24 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>Pain while running</NAME>
<CONT_DATA CI_END="5.081138530665104" CI_START="-11.081138530665104" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="23.0" MODIFIED="2012-05-15 15:20:24 -0400" MODIFIED_BY="[Empty name]" ORDER="12" SD_1="9.0" SD_2="8.0" SE="4.123105625617661" STUDY_ID="STD-Schwellnus-1992" TOTAL_1="9" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.03" MODIFIED="2014-10-27 03:57:38 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>% of maximum pain while running</NAME>
<CONT_DATA CI_END="3.7719969162763376" CI_START="-3.971996916276337" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.1" MODIFIED="2012-05-15 15:20:41 -0400" MODIFIED_BY="[Empty name]" ORDER="13" SD_1="5.0" SD_2="3.0" SE="1.9755449318549496" STUDY_ID="STD-Schwellnus-1992" TOTAL_1="9" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-10-27 04:43:53 -0400" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-09-24 13:16:05 -0400" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAcUAAAJaCAYAAABeGVyPAABMEklEQVR42u2dAWRW3//HfyRJkkiS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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-10-27 04:43:52 -0400" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2014-10-27 04:43:53 -0400" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAUoAAAGRCAIAAACMsm2+AAASUElEQVR42u3dP29dRRPHcUtIiMJF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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-10-28 13:08:33 -0400" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2014-10-28 13:08:33 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-05-18 12:44:53 -0400" MODIFIED_BY="[Empty name]">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-28 13:08:33 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Ovid MEDLINE(R) In-Process &amp; Other Nonindexed Citations, and Ovid MEDLINE(R) (1946 to July 1, 2014)</B>
</P>
<P>1 exp Tendinopathy/ (6229)</P>
<P>2 tendinopath$.tw. (1352)</P>
<P>3     tend?nit$.tw. (2331)</P>
<P>4     tend?nos$.tw. (576)</P>
<P>5     ECRT.tw. (11)</P>
<P>6     tennis elbow.tw. (650)</P>
<P>7     lateral$ epicondylitis.tw. (507)</P>
<P>8     ITBFS.tw. (18)</P>
<P>9     Iliotibial band friction syndrome.tw. (55)</P>
<P>10     exp Cumulative Trauma Disorders/ (10274)</P>
<P>11     (repetiti$ adj (motion disorder or strain)).tw. (358)</P>
<P>12     cumulative trauma disorder$.tw. (273)</P>
<P>13     or/1-12 (18667)</P>
<P>14     exp Musculoskeletal Manipulations/ (11415)</P>
<P>15     physical therapy modalities/ (26485)</P>
<P>16     massag$.tw. (6837)</P>
<P>17     Deep transverse friction.tw. (6)</P>
<P>18     dtfm.tw. (2)</P>
<P>19     Cyriax.tw. (31)</P>
<P>20     or/14-19 (41129)</P>
<P>21     13 and 20 (534)<BR/>
<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2014-10-27 03:58:48 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-10-29 15:38:23 -0400" MODIFIED_BY="[Empty name]">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-27 03:58:48 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Database: EMBASE Classic + EMBASE (1947 to July 1, 2014)</B>
</P>
<P>1     exp massage/ (10894)</P>
<P>2     therapeutic touch.mp. (429)</P>
<P>3     reflexotherapy.mp. (416)</P>
<P>4     exp ROLFING/ (12)</P>
<P>5     exp SHIATSU/ (65)</P>
<P>6     exp reflexology/ (374)</P>
<P>7     myotherapy.mp. (34)</P>
<P>8     (polarity adj therapy).mp. (13)</P>
<P>9     (myofascial adj release).mp. (114)</P>
<P>10     (craniosacral adj therapy).mp. (87)</P>
<P>11     exp REIKI/ (184)</P>
<P>12     (trager adj psychophysical).mp. (6)</P>
<P>13     (hakomi adj method).mp. (2)</P>
<P>14     (jin adj shin).mp. (4)</P>
<P>15     (neuromuscular adj therapy).mp. (10)</P>
<P>16     (pfrimmer adj25 therapy).mp. (4)</P>
<P>17     (alexander adj technique).mp. (85)</P>
<P>18     exp Alexander Technique/ (35)</P>
<P>19     (feldenkrais adj method).mp. (57)</P>
<P>20     massag$.mp. (18532)</P>
<P>21     or/1-20 (19890)</P>
<P>22     exp tendon injury/ (15552)</P>
<P>23     tendinitis/ (6184)</P>
<P>24     tenosynovitis/ (4011)</P>
<P>25     tendinopathy/ (5701)</P>
<P>26     (tend#nitis or tend#nosis or tend#nopathy or tenovaginitis or paratend#nitis or peritend#nitis or tenosynovitis).tw. (7635)</P>
<P>27     or/22-26 (25837)</P>
<P>28     21 and 27 (172)</P>
<P>
<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2014-09-17 14:06:11 -0400" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2012-10-29 15:38:37 -0400" MODIFIED_BY="[Empty name]">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-09-17 14:06:11 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Wiley Cochrane Library &#8211; CENTRAL<BR/>Issue 7 of 12, July 2014</B>
</P>
<P>#1        MeSH descriptor: [Tendinopathy] explode all trees</P>
<P>#2        MeSH descriptor: [Tendon Injuries] explode all trees</P>
<P>#3        (Tendinitis or Tendinosis or Tendonitis):ti,ab</P>
<P>#4        lateral epicondylitis</P>
<P>#5        Iliotibial band friction syndrome</P>
<P>#6        repetitive motion</P>
<P>#7        repetitive strain</P>
<P>#8        #1 or #2 or #3 or #4 or #5 or #6 or #7</P>
<P>#9        Deep transverse friction</P>
<P>#10      massage</P>
<P>#11      MeSH descriptor: [Massage] explode all trees</P>
<P>#12      MeSH descriptor: [Musculoskeletal Manipulations] explode all trees</P>
<P>#13      dtfm</P>
<P>#14      Cyriax</P>
<P>#15      MeSH descriptor: [Physical Therapy Modalities] explode all trees</P>
<P>#16      #9 or #10 or #11 or #12 or #13 or #14 or #15</P>
<P>#17      #8 and #16</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2014-10-27 03:59:23 -0400" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2012-10-29 15:40:34 -0400" MODIFIED_BY="[Empty name]">CINAHL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-27 03:59:23 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>EBSCO Host CINAHL<BR/>1982-July 2014</B>
</P>
<TABLE COLS="3" ROWS="15">
<TR>
<TD VALIGN="TOP">
<P>S15</P>
</TD>
<TD VALIGN="TOP">
<P>S9 and S14</P>
</TD>
<TD VALIGN="TOP">
<P>120</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S14</P>
</TD>
<TD VALIGN="TOP">
<P>S10 or S11 or S12 or S13</P>
</TD>
<TD VALIGN="TOP">
<P>9452</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S13</P>
</TD>
<TD VALIGN="TOP">
<P>TX massage</P>
</TD>
<TD VALIGN="TOP">
<P>9452</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S12</P>
</TD>
<TD VALIGN="TOP">
<P>(MH "Deep Tissue Massage")</P>
</TD>
<TD VALIGN="TOP">
<P>44</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S11</P>
</TD>
<TD VALIGN="TOP">
<P>(MH "Sports Massage")</P>
</TD>
<TD VALIGN="TOP">
<P>166</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S10</P>
</TD>
<TD VALIGN="TOP">
<P>(MH "Massage")</P>
</TD>
<TD VALIGN="TOP">
<P>5733</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S9</P>
</TD>
<TD VALIGN="TOP">
<P>S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8</P>
</TD>
<TD VALIGN="TOP">
<P>3869</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S8</P>
</TD>
<TD VALIGN="TOP">
<P>"tendinitis"</P>
</TD>
<TD VALIGN="TOP">
<P>407</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S7</P>
</TD>
<TD VALIGN="TOP">
<P>"repetitive strain"</P>
</TD>
<TD VALIGN="TOP">
<P>157</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S6</P>
</TD>
<TD VALIGN="TOP">
<P>(MH "Cumulative Trauma Disorders")</P>
</TD>
<TD VALIGN="TOP">
<P>1667</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S5</P>
</TD>
<TD VALIGN="TOP">
<P>"ECRT"</P>
</TD>
<TD VALIGN="TOP">
<P>1</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S4</P>
</TD>
<TD VALIGN="TOP">
<P>"lateral epicondylitis"</P>
</TD>
<TD VALIGN="TOP">
<P>240</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S3</P>
</TD>
<TD VALIGN="TOP">
<P>(MH "Elbow Injuries")</P>
</TD>
<TD VALIGN="TOP">
<P>579</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S2</P>
</TD>
<TD VALIGN="TOP">
<P>(MH "Tennis Elbow")</P>
</TD>
<TD VALIGN="TOP">
<P>645</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>S1</P>
</TD>
<TD VALIGN="TOP">
<P>(MH "Tendinopathy")</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2014-10-27 03:59:40 -0400" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2012-10-29 15:41:24 -0400" MODIFIED_BY="[Empty name]">PEDro search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-27 03:59:40 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>PEDro</B>
</P>
<P>Therapy: stretching, mobilization, manipulation and massage</P>
<P>Problem: pain</P>
<P>Body part: forearm elbow</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2014-10-27 03:59:57 -0400" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2012-10-29 15:42:09 -0400" MODIFIED_BY="[Empty name]">Clinicaltrials.gov search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-27 03:59:57 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Clinicaltrials.gov</B>
</P>
<P>Conditions: tendinitis OR tenosynovitis OR tendinopathy<BR/>Interventions: massage</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;28 full-text articles assessed for eligibility&lt;/span&gt;&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;34 potential records screened&lt;/span&gt;&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;853 records after duplicates removed&lt;/span&gt;&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;951 records identified through database searching&lt;br&gt;MEDLINE = 534&lt;br&gt;EMBASE = 172&lt;br&gt;CENTRAL = 121&lt;br&gt;&lt;span&gt;CINAHL = 124&lt;/span&gt;&lt;br&gt;PEDro = 0&lt;br&gt;&lt;/p&gt;" WIDTH="189"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;1 additional record identified through Clinicaltrials.gov&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;6 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;&lt;span&gt;26 full-text articles excluded, with reasons&lt;/span&gt;&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>